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Globally, cardiovascular disease (CVD) is the leading cause of death.  Increased risk for 
CVD can be attributed to smoking, high blood pressure, poor lipid profiles, obesity and 
psychosocial factors.  Markers of subclinical CVD are non-invasive measures that detect 
early atherosclerotic changes.   The purpose of this dissertation was to evaluate novel risk 
factor associations for subclinical CVD in three distinct populations.  
The protective effect of HDL-c for subclinical CVD was diminished in a population of 
postmenopausal women compared to premenopausal women.  Furthermore, the 
concentration of small HDL particles was higher among postmenopausal women.  Lipid 
profile changes with the menopausal transition may in part explain the increased risk of 
CVD seen after menopause. 
The protective effect of education for subclinical CVD was evident only among 
females from an Afro-Caribbean population.  Educational differences in SBP and lipids 
varied for males and females providing insight into potential mechanisms for the education-
subclinical CVD relationship observed on the island of Tobago. 
Tonic cardiac sympathetic activity and parasympathetic reactivity were independent 
predictors of subclinical CVD in a population of overweight and obese young adults.  The 
effect of C-reactive protein (CRP) on subclinical CVD is potentially explained by the 
autonomic anti-inflammatory mechanisms linking heart rate variability and CRP.  
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Identifying novel risk factor associations for subclinical CVD in various populations 
supports the important public health objective of reducing the global burden of CVD 
morbidity and mortality through early detection of atherosclerosis. 
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1.0 DISSERTATION OVERVIEW AND OBJECTIVES 
 
Globally, cardiovascular disease (CVD) is the leading cause of death.  Increased risk for 
CVD can be attributed to smoking, high blood pressure, poor lipid profiles, obesity and 
psychosocial factors.  Markers of subclinical CVD are non-invasive measures that detect 
early atherosclerotic changes.  These measures are associated with traditional CVD risk 
factors and have shown to predict future cardiovascular events.   
The intention of this dissertation is to evaluate novel risk factor associations for 
subclinical CVD in three distinct populations.  The three aims and study populations are 
described below: 
   
1. As women transition through menopause their risk for CVD increases.  It is plausible 
that adverse lipid profile changes during the transition may explain a portion of this 
increased risk.  SWAN Heart, an ancillary study to SWAN (Study of Women’s Health 
Across of the Nation), assessed subclinical CVD during the menopausal transition.  
The aim of this manuscript was to determine if the relationship between lipids and 
subclinical CVD varies by menopausal status.  Understanding the mechanisms that 
promote early CVD in women may lead to new preventative efforts or delay disease 
onset in the postmenopausal years. 
 
2. Education is protective against adverse health outcomes; however the effect of 
education on CVD has shown to be steeper among females.  This manuscript aimed 
to determine the association between education and subclinical CVD in a 
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community-based sample of Afro-Caribbean males and females from the Tobago 
Family Health Study.  Differences in CVD risk factors by education may offer 
potential mechanism for gender differences in the education-subclinical CVD 
relationship.  
 
3. Heart rate variability (HRV) and C-reactive protein (CRP) are known markers of 
CVD.  Autonomic nervous system activity, as measured by HRV, modulates 
inflammation.  The primary aim of this manuscript was to determine which CVD risk 
factors predicted HRV, CRP and subclinical CVD and how HRV and CRP together 
predicted subclinical CVD in a population of moderately overweight and obese 
young adult men and women from the study to Slow Adverse Vascular Effects 
(SAVE).  Using measures of tonic sympathetic and parasympathetic outflow 
simultaneously and including HRV reactivity to standard autonomic challenges may 
provide further evidence into how the autonomic nervous system relates to early 
atherosclerotic changes.  
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2.0 GENERAL INTRODUCTION 
 
 
2.1 CARDIOVASCULAR DISEASE 
 
Cardiovascular disease (CVD) is the leading cause of death in the world 1.  In 2004, 32% of 
mortality among females and 27% among males were due to myocardial infarction and 
stroke.  A dramatic increase from 17.5 million CVD deaths in 2005 to 24.2 million in 2030 is 
projected 2.  The estimated cost of CVD in the United States is $475.3 billion for 2009 3.  
Worldwide, over 80% of CVD mortality occurs in low to middle income developing countries 
4.  There is tremendous economic growth potential lost in these countries because CVD 
death occurs among the working aged 5.  Given the large economic impact and premature 
death, prevention is imperative in reducing the global burden of CVD.  Identifying novel risk 
factor associations with subclinical CVD can facilitate the stratification of individuals at 
increased risk for early CVD.     
 
2.2 ATHEROSCLEROSIS 
 
Atherosclerosis is the initial process that ultimately leads to myocardial infarction and stroke 
6, 7.  Luminal occlusion begins with repeated damage to the endothelium.  Inflammation, 
toxins and oxidized LDL-c are hypothesized mechanisms of vascular injury.  Following 
injury, monocytes attach to the endothelium due to increased adhesion molecule expression 
and migrate into the intimal layer where they develop into macrophages.  These 
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macrophages accumulate lipids, referred to as foam cells, and together with lymphocytes, 
become fatty streaks.  If these streaks are allowed to progress, as the result of continued 
CVD risk factor exposure, they will eventually become plaques.  Fibrous plaques are 
composed of foam cells and layers of smooth muscle cells.  Atherosclerotic changes 
progress to incident CVD as a result of cumulative plaque burden, arterial lumen narrowing 
and vulnerability of the lesions 8.  Large lesions with thin fibrous caps and vascular 
remodeling are factors that promote plaque rupture and subsequent hemorrhage and 
thrombosis, resulting in vessel occlusion 9.   
 
 
2.3 SUBCLINICAL CARDIOVASCULAR DISEASE 
 
Subclinical CVD measures are non-invasive techniques that allow for the early detection of 
vascular changes due to aging and other risk factors.  The following measures are used in 
this dissertation and appear in chapters 3, 4 and 5.   
 
2.3.1 Carotid Intima Media Thickness 
 
Carotid intima media thickness (IMT) is a measure of the inner two layers of the arterial 
wall.  B-mode ultrasound is a non-invasive technique that is used to capture reliable 
measures of IMT 10.  Arterial wall hypertrophy and dilation occur with vascular adaptation to 
increased blood pressure and atherosclerosis 11, 12.  These changes maintain shear and 
tensile stresses.  IMT is primarily a result of intimal hypertrophy 13.  However, ultrasound 
techniques are not sensitive enough to capture only the intimal layer and therefore the 
intima and media are measured collectively 10.  
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IMT has shown to be an independent predictor of incident CVD: myocardial 
infraction, stroke and mortality 14-20.  In addition, IMT is associated with traditional CVD risk 
factors such as age, male gender, lipids, smoking, glucose and blood pressure 14, 17, 21-26.  A 
linear increase in IMT has been observed with increasing age among healthy adults 24.  The 
increased risk of incident CVD seen with increasing IMT is similar to the observed increase 
with age, suggesting IMT is good measure of vascular aging 27.  IMT changes have been 
noted with SBP above 120 mmHg and these changes were independent of other CVD risk 
factors 25.   A 40 mg/dL increase in LDL-c was associated with a 0.02 to 0.05 mm increase 
in IMT 26.  Small changes in IMT indicate large changes in risk.  For example, the odds of 
myocardial infarction and stroke increased 25% and 34%, respectively, over a 3 year period 
for a 1 SD increase in IMT (0.163mm) 28.  Although IMT is not necessarily synonymous with 
atherosclerosis, it is likely the result of similar factors as plaque formation given the strong 
associations with traditional risk factors 10.  This in conjunction with its ability to predict 
incident CVD makes IMT a valuable subclinical measure of CVD. 
 
2.3.2 Arterial and Lumen Diameter  
 
As with intima media thickness, adventitial and lumen diameter (AD and LD, respectively) 
are obtained from B-mode ultrasound imaging.  The AD is the distance between the 
adventitial and medial interfaces on the near and far wall, while the LD is the distance 
between the intima and lumen interfaces.  An intraclass correlation coefficient of 0.99 has 
been previously reported for AD 29.  Traditional CVD risk factors, such as age, weight, SBP, 
glucose and HDL-c have been shown to be independently associated with AD in a 
population of older adults from the EVA study 30. 
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Larger diameters result from outward remodeling due to age related decreases in 
arterial wall elastin and mechanical stress 31, 32.  In a subset of non-smoking ARIC 
participants free of known CVD, diabetes, hypertension, obesity or hyperlipidemia, AD was 
positively associated with age, suggesting outward remodeling is independent of known 
CVD risk factors.  Besides age associated remodeling, AD increases with hemodynamic 
changes seen with plaque formation.  AD was shown to be higher among postmenopausal 
women with carotid plaque compared to women without plaque in a case-control study 
matched on age and adjusted for HDL-c and SBP 33.   
In addition to outward remodeling, hypertrophy occurs as a result of risk factor 
exposure.  Consequently, increases in AD may mask IMT changes.  Therefore, AD and IMT 
should be evaluated simultaneously as predictors of incident CVD.  In a subset of ARIC 
participants, AD was an independent predictor of incident CVD after adjusting for traditional 
risk factors and carotid IMT 34. 
   
2.3.3 Carotid Plaque  
 
Eccentric carotid plaque develops as a result of atherosclerotic progression within the 
vessel wall.  Plaque is often distinguished from IMT on ultrasound imaging as focal 
protrusion greater than 50% of the surrounding arterial wall.  IMT is a potential precursor for 
carotid plaque given its positive correlation independent of traditional risk factors and its 
modest predictability of carotid plaque (R2 = 0.23) 35, 36.  Traditional CVD risk factors, such 
as age, SBP, smoking, BMI and glucose have shown to predict carotid plaque 37.  In 
addition, among several large longitudinal studies, carotid plaque has predicted myocardial 
infarction, stroke and death 19, 38, 39.   
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2.3.4 Aortic Calcification 
 
Electron beam computed tomography (EBCT) is a non-invasive method that requires 
minimal radiation exposure to detect calcified aortic plaques. Age, gender, diabetes, lipids, 
SBP and smoking have been shown to predict aortic calcification (AC) 40. The Framingham 
Heart study observed a 6 to 8 fold increase in AC over a 25 year follow up 41.  Unlike 
coronary calcification, where males tend to have much higher rates compared to females, 
AC differences by gender were less striking in the Rotterdam Study 22.  A 20mg/dL increase 
in LDL-c was associated with an OR for AC of 1.33 (95% CI: 1.0, 1.8) whereas a 10mg/dL 
increase in HDL-c was associated with an OR of 0.70 (95% CI: 0.47, 1.0) 42. 
 
2.3.5 Pulse Wave Velocity 
 
Pulsatile blood flow is converted to continuous flow by stored energy in compliant vessel 
walls and pressure wave reflection 43.  Arterial stiffening due to vascular aging and 
hypertrophy of the vessel wall leads to noncompliant vessels and subsequently increased 
pulse pressure and decreased coronary blood supply during diastole 44, 45.  Pulse wave 
velocity (PWV) is a highly reproducible method of choice for assessing arterial stiffening 46, 
47.  The Rotterdam study observed a significant association between PWV and IMT, carotid 
plaque, aortic calcification and peripheral artery disease 48.  In addition, to predicting other 
measures of subclinical atherosclerosis, increased PWV is related to CVD events and 
mortality 49-51.  The Health ABC study observed a > 50% increase in incident CVD among 
those in the top 25th percentile of PWV. 
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2.4 CARDIOVASCULAR RISK FACTORS 
 
A vast number of risk factors have been established as independent predictors for 
subclinical and clinical CVD 52.  These risk factors include, but are not limited to: age, lipids, 
weight, gender, socioeconomic status and heart rate variability.  Assessment of these 
factors among various populations can help with risk stratification and determine 
mechanism for disease development.  The following risk factors are evaluated in this 
dissertation and appear in chapters 3, 4 and 5. 
 
2.4.1 Menopause 
 
Menopause is the cessation of menses due to ovarian follicular inactivity 53.  The 
menopausal transition begins with changes to the regular menstrual cycle and ends when 
menstruation has stopped for one year.  Natural menopause occurs between 45 to 55 years 
of age and lasts 4 to 5 years on average 53, 54.  Hormones are known to fluctuate on a day-
to-day basis as women transition through menopause, with a gradual decrease in estrogen 
and an increase in follicular stimulating hormone (FSH) over time.  Estrogen is known to 
increase vasodilation, reduce vascular injury and reduce smooth muscle cell proliferation.  
In addition, a decrease in LDL-c, an increase in HDL-c and a reduction of LDL-c oxidation 
have been documented.  Therefore, menopause is associated with a decrease in a 
hormone that has cardioprotective effects. 
 The decline in estrogen that accompanies menopause is thought to contribute to the 
increased risk for CVD that is observed among postmenopausal women 55, 56.  However, it 
is also possible that the increased risk that accompanies the 4-5 year menopausal transition 
is a function of older age.  Thus, the role of age should be considered in examining whether 
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menopausal changes in hormones contribute to CVD risk. Simple adjustment may not 
account for the entire effect of age if the range is too wide and there is little overlap between 
the pre- and postmenopausal groups.  Therefore, careful consideration in recruitment needs 
to be addressed in order to reduce bias and differentiate risk associated with hormonal 
changes from age-related increases in risk 57.  
Growing evidence shows that a number of factors contribute to menopause-related 
increases in CVD risk that are independent of age 58.  Both total cholesterol and LDL-c have 
been shown to be higher among the post- than pre-menopausal group 59.  The Study of 
Women’s Health Across the Nation showed a significant difference in LDL-c from pre- to 
post-menopause (116.3 vs. 123.4 mg/dL, p <0.0001).  Weight gain over the menopausal 
transition is most likely due to chronological aging; however, increases in visceral adiposity 
and decreases in lean mass have been attributed to menopause 60, 61.  In the Vermont 
Longitudinal Study of the Menopause, postmenopausal women had higher fat mass and 
higher intra-abdominal adiposity compared to premenopausal women (18 vs. 23 kg, p<0.01 
and 65 vs. 77 cm2, p<0.05). 
 
2.4.2 Lipoproteins 
 
Low density lipoprotein cholesterol (LDL-c) and high density lipoprotein cholesterol (HDL-c) 
are often referred to as the ‘bad’ and ‘good’ cholesterol; however, they are not types of 
cholesterol, but rather different transporters of lipids and proteins 62.  LDL-c has shown to be 
directly related to the risk of CHD in a large population of Japanese men and women 63.  
However, LDL-c levels alone may not accurately characterize lipid profiles 64, 65.  Two 
individuals may have similar LDL-c levels; however, the number of particles carrying that 
cholesterol may vary greatly. NMR spectroscopy measures the total number of terminal 
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methyl groups in each lipoprotein particle, thereby approximating the diameter of the 
lipoprotein 64.  This method provides an estimate of the particle concentration rather than 
the amount of cholesterol being carried by the particles.   
Several studies have concluded small LDL particles are more atherogenic compared 
to large particles 65.  However, the MESA study, a large population of relatively healthy men 
and women, ages 45 to 84 years, demonstrated that both small and large LDL particles 
were predictors of subclinical CVD, and only when the inverse correlation between small 
and large particles was accounted for was this association apparent 66.  It has been 
suggested that LDL particle number is a more informative risk factor compared to LDL-c or 
LDL particle size 65. 
HDL-c is inversely related to CVD.  It exerts its protective effects through reverse 
cholesterol transport from the periphery to the liver for secretion with bile 67.  In addition, 
HDL-c is known for its anti-atherogenic properties, such as inhibition of adhesion molecules 
and LDL-c oxidation 68.  The protective properties of HDL-c may not be equally shared 
between large and small particles 69.  In a population of adult men with a known history of 
myocardial infarction, small HDL particles were directly related to the progression of 
coronary atherosclerosis, while large particles were inversely related 70.  Therefore, HDL 
particle size, as a CVD risk factor, may provide additional information beyond HDL-c. 
 
2.4.3 Education 
 
Socioeconomic status (SES) is a complex combination of education, income and 
occupation 71, 72.  Using more than one measure of SES is ideal because the three 
measures contribute different information, however, education is the variable most often 
used in epidemiology research 73.  It has shown to be reliable and valid 74.  Education is a 
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measure of social, psychological and economic resources.  It influences behavior, problem 
solving and values.  Since education is attained early in life, it does not reflect changes in 
SES or accumulation of SES in adulthood 75.  Income and occupation reflect a more current 
status of adulthood SES.  However, income and occupation are difficult to analyze among 
the unemployed, homemakers or retired.  In addition, it is possible that health status could 
influence occupation and subsequently income.  Education may improve health related 
knowledge and allow for favorable occupation and income in adulthood. 
Education has been shown to be a strong predictor of traditional CVD risk factors 
and disease.  In a study of Scottish males, occupation was a stronger predictor of all cause 
mortality, but when individual causes of mortality were explored, education was strongly 
associated with cardiovascular mortality 73.  Using US census data, education was inversely 
associated with mortality 76.  Income did not account for additional variation in mortality.  
When income was substituted for education, traditional CVD risk factors explained the 
majority of the association between income and CVD events 77.  
 
2.4.4 Autonomic Nervous System 
 
The autonomic nervous system (ANS) is a component of the peripheral nervous system 
consisting of two main branches, the sympathetic and the parasympathetic.  The 
sympathetic and parasympathetic branches innervate the sinoatrial node of the heart and 
regulate heart rate variability 78.  Vasculature tone is achieved via sympathetic 
vasoconstriction and parasympathetic vasodilation 79.  The ANS is responsible for 
maintaining vascular homeostasis when the system is disturbed.  For example, during a 
rapid standing position, blood will pool in the lower extremities.  As a result, there is 
decreased cardiac return and subsequently decreased cardiac output. This drop in blood 
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pressure triggers the sympathetic branch to increase heart rate and peripheral resistance in 
order to restore the arterial pressure 80.    
Heart rate variability (HRV) is a well known and validated method to measure the 
ANS.  This method has produced reproducible results in reliability studies 81.  Heart rate and 
respiratory rate variability, from the electrocardiogram and bioimpedance plethysmography, 
respectively, is converted to quantitative estimates of ANS function via spectral analysis 82-
84.  From the classic frequency domain analysis, the high frequency peak (HF) has been 
shown to correlate with parasympathetic (vagal) activity; however, the low frequency peak 
(LF) is believed to be a combination of sympathetic and parasympathetic activity.  These 
interpretations are based on pharmacologic studies observing a reduction in the LF peak 
with sympathetic blockade, but a reduction in both LF and HF peaks with parasympathetic 
antagonist 78.  Another concern is slower respiratory rates can cause false elevations in LF 
85, 86. To address these problems, a new method was created to take into account 
respiratory rate.  By isolating the respiratory peak on the respiratory rate spectral analysis, 
and centering the HF component at this frequency, parasympathetic and sympathetic 
activity estimates are improved 86.   
Measures of HRV have been associated with increased risk of CHD and mortality.  
The ARIC study, a population based cohort of adult men and women, ages 45 to 64 years, 
found a significant inverse association (RR = 1.72, 95% CI: 1.17-2.51) for CHD in the lower 
quartile of HF compared to the upper three quartiles 87.  No significant association was 
observed for LF or LF/HF ratio, a possible measure of sympathovagal balance.  A decrease 
in all HRV measures, except LF/HF ratio, was associated with a significant increase in the 
risk of incident CVD among the Framingham Heart Study cohort 88.  The lack of association 
of CHD and LF in the ARIC study and the inverse association in the Framingham study may 
reflect the mixture of sympathetic and parasympathetic activity within the LF component. 
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2.4.5 C-Reactive Protein 
 
C-Reactive Protein (CRP) is a marker for low-grade systemic inflammation that can be 
measured in peripheral circulation 89.  Inflammation is involved in the atherosclerotic 
process from vascular injury and endothelial dysfunction to foam cell development and 
plaque rupture. Cytokines produced during atherosclerotic progression, specifically, IL-1, IL-
6, and TNF-α, are known to trigger the acute phase response, which includes the 
production of CRP by hepatocytes 90.  In addition, IL-6 and CRP are produced by 
adipocytes, which may account for the positive associations of weight with circulating levels 
of CRP 91.  
CRP is an inexpensive and widely available marker of general inflammation 92.  The 
mechanism by which CRP is related to the progression of atherosclerosis is complex.  A 
significant association has been observed with age, smoking, BMI, lipids, clotting factors 
and glucose 93.  CRP has proven to be a sensitive marker of incident CVD in a general 
population of British men 94.  The adjusted odds ratio for CHD was 2.13 (95% CI: 1.38, 3.28) 
for the top tertile of CRP compared to the bottom.  The Women’s Health Study showed an 
adjusted relative risk of 1.5 (95% CI: 1.1, 2.1) for CVD events (myocardial infarct, stroke, 
revascularization and death) in a population of postmenopausal women 95. Despite its 
predictability, the benefit of therapeutic reduction in CRP is debatable given the lack of a 
casual association observed in a genetics study 83.  In addition, CRP was not found to 
improve risk stratiifcation over convential factors in a large population of Swedish men and 
women 96.  Nevertheless, CRP can assist in the explanation of atherosclerotic disease 
mechanims.  
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2.5 STATISTICS 
 
2.5.1 Multinomial Logistic Regression  
 
Multinomial logistic regression (MLR) and ordinal logistic regression (OLR) are used when 
the outcome measure is a categorical variable with more than two levels 97.  Nominal 
outcomes are analyzed with MLR and ordinal outcomes by OLR.  OLR takes into account 
the rank order of the outcome when calculating the odds ratio, but requires that the 
predictor variables have the same effect on each ordered outcome level.  When the logistic 
regression model does not meet this assumption of proportional odds, results can be 
misleading and MLR should be used 98.  MLR generates an odds ratio for each pair of 
outcome measures; however, it does not consider the order of the outcome measure. 
 In chapter 3, aortic calcification, a three level categorical measure (none, moderate 
and high), is one of the key outcome variables assessed.  The three levels are ordinal in 
nature; however, the assumption of proportional odds was violated.  Therefore, MLR was 
the method of choice when analyzing aortic calcification.   
 
2.5.2 Collider Bias  
 
Collider bias can occur when exposure and disease influence a third variable (C) and the 
association between exposure and disease is conditioned upon C 99, 100.  If sample selection 
or stratification is based on C this can create a collider bias; the results from these data 
analyses may misrepresent the true relationships between the variables and false 
conclusions may be drawn regarding causality.  The direction of the associations between 
exposure, disease and C is critical.  If C causes disease and C is related to exposure then 
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stratifying on C would remove bias (confounding).  However, if exposure and disease affect 
C then the observed change in the association estimate is biased.  The effect of exposure 
on C or disease on C does not have to be direct, it can occur through other measured or 
unmeasured variables. 
 The manuscripts in chapters 3 and 4 both include interactions in the model; 
therefore, it was necessary to rule out the possibility for collider bias.  Chapter 3 assessed 
the association between HDL-c and subclinical CVD by menopausal status.  It is unlikely 
that HDL-c (exposure) or subclinical CVD (disease) influences menopausal status (C), 
therefore, the risk for collider bias is small. However, it is plausible that other measured or 
unmeasured factors may affect menopausal status; thus the potential for collider bias is still 
possible. In addition, chapter 4 evaluated the effect of education on subclinical CVD among 
a population of Tobagonian males and females.  Since education (exposure) and subclinical 
CVD (disease) do not determine ones gender (C), conditioning on gender is acceptable. 
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3.1 ABSTRACT 
 
Background: The risk of cardiovascular disease increases after menopause.  Changes in 
the lipoprotein profile may in part be responsible for this trend.  Evaluating the contribution 
of HDL cholesterol (HDL-c) to subclinical cardiovascular disease across the menopausal 
transition would provide insight for this increased risk.  Methods: Aortic calcification (AC), 
carotid plaque and intima media thickness (IMT) were measured in Pittsburgh and Chicago 
women enrolled in an ancillary study to the Study of Women’s Health Across the Nation 
(SWAN).  Women were stratified into two menopause groups; premenopausal or early 
perimenopausal (Pre/EP) and late perimenopausal or postmenopausal (LP/Post).  Results: 
On average Pre/EP women were 49 years of age and LP/Post women were 52 years of 
age.  LP/Post women had slightly higher HDL-c levels compared to Pre/EP women (59 vs. 
56 mg/dL, p = 0.04).  Across all women, HDL-c was negatively associated with high and 
moderate AC, any carotid plaque and IMT in univariate analysis.  However, interactions 
between menopause status and HDL-c were statistically significant for AC and IMT in fully 
adjusted models (p = 0.01, 0.03), but borderline for any carotid plaque (p = 0.08).  In 
multivariable models, Pre/EP women demonstrated a negative association between HDL-c 
levels and moderate AC (OR = 0.97, 95%CI 0.94, 1.00), high AC (OR = 0.98, 95%CI 0.94, 
1.02), any carotid plaque (OR = 0.97, 95%CI 0.94, 1.00) and IMT (β = -0.001, 95%CI -
0.002, -0.0002), however only IMT showed a significant association.  In LP/Post women, a 
positive association between HDL-c levels and moderate AC (OR = 1.03, 95%CI 1.00, 
1.06), high AC (OR = 1.05, 95%CI 1.01, 1.09), any carotid plaque (OR = 1.01, 95%CI 0.98, 
1.03) and IMT (β = 0.0002, 95%CI -0.0006, 0.0009) was observed, but was only significant 
for high AC.  In the small sub sample of Pittsburgh women, LP/Post women had more small 
18 
 
HDL particles (HDL-p) compared to Pre/EP women.  Conclusion: In conclusion, the 
protective effect of HDL-c appears to diminish in LP/Post women compared to Pre/EP 
women.  This loss of protection may be due to increased concentrations of small HDL-p. 
 
3.2 INTRODUCTION 
 
Cardiovascular disease (CVD) contributes to 39 percent of mortality in American women 1.  
As women age they are increasingly exposed to major CVD risk factors, including a poor 
lipid profile and weight gain.  In addition to chronological aging, women experience the 
biological changes of the menopausal transition.  The largest increase in CVD rates around 
the menopausal transition adds additional risk above and beyond chronologic aging 2.  
Decreasing estrogen levels have been linked to endothelial dysfunction and poor vascular 
tone 3-5.  However, there may be additional mechanisms through which the menopausal 
transition confers CVD risk. 
Lipids are known to change in association with both age and the menopausal 
transition 6, 7.  Understanding these changes, including how they contribute to early vascular 
disease, may provide evidence to the underlying mechanism(s) that increases CVD risk 
following the transition.  During the transition, low density lipoprotein cholesterol (LDL-c) 
levels increase, while high density lipoprotein cholesterol (HDL-c) levels tend to remain 
stable or increase slightly 8-12.  It is widely accepted that increasing levels of LDL-c promote 
CVD while increasing levels of HDL-c are protective.  However, no studies have yet 
evaluated whether or not these associations are consistent across the stages of 
menopause.  One study has suggested that the protective effects of HDL-c on IMT may 
diminish over time in middle aged-women 13.  
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The Study of Women’s Health Across the Nation (SWAN) provides a unique 
opportunity to determine if the relationship between lipids and CVD varies by menopausal 
status.  SWAN has explored biological changes as women have transitioned through 
menopause, including subclinical CVD measures in two of the seven sites.  Subclinical CVD 
measures are reliable measures of the atherosclerotic process 14.  Accordingly, the purpose 
of this study was to evaluate whether the menopausal transition modifies the contribution of 
lipids to subclinical CVD, specifically, aortic calcification (AC), carotid plaque and intima 
media thickness (IMT).  These non-invasive subclinical measures have been shown to 
predict clinical events including stroke, myocardial infarction and cardiovascular death in 
large population studies 15-19.  These studies have shown independent positive associations 
between subclinical measures and the following traditional CVD risk factors: increasing age, 
African American race, hypertension, obesity, hyperlipidemia, diabetes and smoking 20.  
Therefore, subclinical measures can be used to evaluate risk factor associations and 
possible differences in these associations by menopausal status.  Understanding 
mechanisms that promote early CVD in women may lead to new preventative efforts or 
delay CVD in the postmenopausal years. 
 
3.3 METHODS 
 
3.3.1 Study Population 
 
The study population for this analysis included 540 women who participated in SWAN 
Heart, an ancillary study to the Study of Women’s Health Across the Nation.  Detailed study 
design and recruitment descriptions for SWAN have previously been published 21.  In brief, 
this multi-center, community-based, longitudinal study recruited women from 7 clinical sites 
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(Chicago, IL; Pittsburgh, PA; Boston, MA; Detroit, MI; Newark, NJ; Oakland, CA; and Los 
Angeles, CA) to assess the biological and psychological changes associated with the 
menopause transition.  Baseline enrollment of 3302 women between the ages of 42 and 52 
years took place during 1996 to 1997.  Only women who had an intact uterus and at least 
one ovary, menstruated in the prior 3 months and not taken hormone therapy or oral 
contraceptives in the prior 3 months were eligible for the parent project.  Women who were 
pregnant or breast feeding were excluded.   
 The ancillary study, SWAN Heart, evaluated 608 women for subclinical CVD.  
Baseline enrollment at the Pittsburgh and Chicago sites occurred between 2001 and 2003 
(corresponding to the 4th - 7th annual SWAN visits).  Women were ineligible for SWAN Heart 
if they had a history of CVD (angina, myocardial infarction, congestive heart failure, stroke, 
transient ischemia attack or vascular surgery), had a hysterectomy or bilateral 
oophorectomy since the start of SWAN, were pregnant or were taking diabetic or hormone 
therapy.  Women were excluded from this analysis for CVD history (n=2), 
hysterectomy/oophorectomy (n=16), diabetes (n=1) and hormone therapy (n=32).  An 
additional 17 women were excluded due to missing menopausal status or no subclinical 
vascular measures collected, resulting in a final sample size of 540 (89%) for this analysis.  
 Research protocols for SWAN and SWAN Heart were approved by the site specific 
institutional review boards and all women provided informed consent prior to enrollment.   
 
3.3.2 Subclinical Measures 
 
Aortic calcification (AC) was quantified using electron beam computed tomography (EBCT; 
Imatron C-150 Ultrafast CT Scanner, GE Imatron, San Francisco, CA).  An initial scout scan 
was done to identify anatomical landmarks.  Next, the scanner obtained cross-sectional 6 
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mm images with a 300 ms exposure time from the aortic arch to the iliac bifurcation.  
Participants were exposed to a total of 2.45 rads during the aortic scan.  All scans were 
saved to optical disc and read centrally at the University of Pittsburgh using a DICOM 
workstation and Acuimage software (South San Francisco, CA).  Using the Agatston 
scoring method, 3 contiguous pixels > 130 Hounsfield units was used to determine the 
presence of lesions within the aorta.  A total calcium score was calculated for the entire 
vessel by one blinded physician trained in EBCT.    
 Carotid intima media thickness (IMT) and carotid plaque assessment were made 
using B-mode ultrasound (Pittsburgh site: Toshiba American Medical Systems, Tustin, CA 
and Chicago site: Hewlett Packard, Andover, MA).  Right and left carotid arteries were 
scanned to obtain a total of 8 images: near and far wall of common carotid (1 cm proximal 
to bulb), far wall of carotid bulb (starting from the point where the common carotid walls are 
no longer parallel and ending at the flow divider) and far wall of internal carotid artery (distal 
1 cm from flow divider).  Semi-automated reading software (AMS system developed in 
Sweden by Dr. Thomas Gustavsson) took 140 measurements of IMT from the leading edge 
of the intima to the trailing edge of the media over the 1 cm segment.  The mean IMT of 
each of the 8 IMT segments was determined, and the average of these 8 mean measures 
was computed for the outcome variable in this analysis.  Carotid plaques were identified as 
discrete focal protrusions > 50% of the surrounding wall thickness.  These plaques were 
graded from 1 to 3 based on the size and number.  The cumulative plaque grades for the 
left and right carotid arteries were summed to generate a plaque index. Image readings 
were performed centrally at the University of Pittsburgh Ultrasound Research Laboratory 
(URL; Pittsburgh, PA).  Reproducibility of IMT during annual recertifications and plaque 
readings from previous work in the URL are as follows: intraclass correlation coefficients for 
IMT 0.98 and plaque 0.86 to 0.93 22, 23.  
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3.3.3 Covariates 
 
SWAN collected annual self- and interviewer-administered questionnaires, fasting blood 
glucose and lipid laboratory measures, anthropometric measures and blood pressure 
readings.  Data from these annual SWAN clinic visits (4th visit: n=272, 5th visit: n=231, 6th 
visit: n=20 and 7th visit: n=17) were matched to participant’s baseline SWAN heart 
subclinical measures in this cross-sectional analysis.  Demographic factors such as age, 
race (only Caucasian and African American race for the Pittsburgh and Chicago sites), 
alcohol and smoking status were obtained through questionnaires.  Participants were asked 
if they had ever smoked on a regular basis defined as at least 20 packs in a lifetime or 1 
cigarette per day for at least one year.  They were also asked the number of servings of 
beer, wine or liquor they consumed on an average day, week or month.  Based on self-
reported bleeding history, menopausal status was classified as premenopausal (Pre; 
menses in the last 3 months with no irregularity), early perimenopausal (EP; menses in the 
last 3 months with irregularity), late peri-menopausal (LP; no menses for at least 3 months, 
but less than 12 months) and postmenopausal (Post; no menses for at least 12 months).  
Blood pressure was collected by a standard sphygmomanometer in the right arm of 
participants after a 5 minute rest period.  A total of three pressures were collected and the 
last two were averaged.  Waist circumference was collected to the nearest 0.1 cm at the 
narrowest portion of the torso in each participant.  Fasting blood samples were collected 
and analyzed at the Medical Research Laboratories (Lexington, KY).  A hexokinase-coupled 
reaction was used to measure glucose levels (Boehringer Mannheim Diagnostics, 
Indianapolis, IN).  EDTA treated plasma was used to analyze lipids; isolation of HDL-c 
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(mg/dL) was done with heparin-2M manganese chloride and LDL-c (mg/dL) was estimated 
with the Friedewald equation 24.   
 Lipoprotein assays were conducted on blood samples from women at the Pittsburgh 
site (sample collection dates from 1997 to 2001).  Lipoprotein subclasses were determined 
on stored EDTA plasma using an automated nuclear magnetic resonance (NMR) 
spectroscopic assay (LipoScience Inc., NC), with a modification of the method previously 
reported 25, 26.  Briefly, the particle concentrations of the lipoprotein subclasses were derived 
from the measured amplitudes of the characteristic lipid methyl group NMR signals they 
emit.  The following subclasses were analyzed for this study: large LDL particles (LDL-p) 
(21.2-23 nm), small LDL-p (18-21.2 nm), large HDL particles (HDL-p) (8.8-13 nm) and small 
HDL-p (7.3-8.8 nm).  Subclasses were summed to provide total LDL-p and total HDL-p, and 
mean LDL and HDL particle sizes are weighted-averages (i.e. the diameter of each 
subclass multiplied by its relative concentration).  NMR-determined LDL and HDL subclass 
distributions are correlated with those determined by gradient gel electrophoresis 27, 28.   A 
total of 71 SWAN Heart women had lipoprotein data and subclinical CVD measures 
available.  Participants had up to three lipoprotein assays conducted; however, the latest 
date was chosen to match to SWAN Heart subclinical measures.  Those with lipoprotein 
data collected more than 16 months apart from their subclinical measures were excluded 
from this analysis.  Of the remaining 53 women, average collection time from subclinical 
measures was 184.5 days for Pre/EP and 236.3 days for LP/Post women.   
 
3.3.4 Statistical Analysis 
 
The distribution of each continuous variable was examined and variables were log 
transformed or categorized if the distribution was not approximately normal.  Glucose, 
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alcohol consumption, AC and carotid plaque were identified as having skewed distributions 
and large proportions of zero values.  Glucose was log transformed; however, medians 
(IQR) are presented in Table 1 for descriptive purposes.  Alcohol and carotid plaque were 
dichotomized into any or none, and AC was classified as none, moderate and high 
calcification (0, 1-74 and 75+, respectively).  High AC was set at the 75th percentile 29.  
Menopausal status was dichotomized into Pre plus EP menopause (Pre/EP) and LP plus 
Postmenopausal (LP/Post) to maintain a moderate sample size 30.  All remaining variables 
met the guidelines for normality and were treated as continuous.  Two sample t-test and chi-
square test were utilized to compare participant characteristics between Pre/EP and 
LP/Post.    
Univariate and multivariable logistic and linear regression were used to assess the 
association between traditional CVD risk factors and AC, carotid plaque and IMT.  For AC, 
multinomial logistic regression rather than ordinal logistic regression was preferred due to 
unmet assumptions of proportional odds 31.  No AC and no carotid plaque were the 
reference groups for the multinomial and binary logistic regression, respectively.  Stepwise 
regression selection was used to evaluate the inclusion of traditional CVD risk factors in the 
multivariable linear and logistic regression models.  Default p-value entry and exit (p-value = 
0.15) were used, however, final models were chosen to be parsimonious.  Age, site and race 
were variables of interest and therefore kept in the final models.  Waist circumference was 
included in multivariable models since it explained more of the variation compared to BMI.  
Interactions between HDL-c and menopausal status and LDL-c and menopausal status 
were tested in multivariable models with and without adjustments for other covariates.  
Further exploration of the HDL-c interactions was done using a reparameterized model to 
include the effects of HDL-c among Pre/EP and LP/Post women in a single multivariable 
model.  The sub sample of Pittsburgh women (n=53) with available lipoprotein data was 
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compared across menopausal status using a two sample t-test.  These data were not used 
in the regression analysis due to small sample size.  All statistical analyses were completed 
with SAS 9.1. Two-sided p-values ≤ 0.05 were considered statistically significant.  
 
3.4 RESULTS 
 
Of the 540 SWAN Heart participants included in this analysis, 316 (59%) were Pre/EP and 
224 (41%) were LP/Post women (Table 3.1).  Average age was 50 years, with Pre/EP 
women being 3 years younger than LP/Post women.  Approximately 39% were African 
American, 62% drank alcohol and 16% had ever smoked regularly.  These characteristics 
did not differ by menopausal status.  LP/Post women had higher mean HDL-c, LDL-c, SBP 
and glucose compared to Pre/EP.  Following age-adjustment, mean HDL-c and SBP no 
longer differed significantly.  Average BMI for the total group was 29.4 kg/m2.  There was a 
trend towards a higher mean waist circumference in LP/Post women.  In addition, LP/Post 
women had more AC, more carotid plaque and higher IMT on average, however, once 
adjusted for age, only carotid plaque differed between the two groups. 
 In univariate analysis (Table 3.2) the odds of high AC increased with age, LDL-c, 
SBP, glucose, waist circumference, smoking and postmenopausal status.  Higher HDL-c 
and alcohol use were significantly associated with lower odds of high AC.  African American 
race was significantly associated with higher odds of moderate AC, but was not statistically 
significant associated with high AC.  For carotid plaque, only age, LDL-c and 
postmenopausal status significantly increased the odds of any carotid plaque, while alcohol 
use lowered the odds of any carotid plaque.  Thicker IMT was seen with increasing age, 
LDL-c, SBP, glucose, waist circumference, African American race and postmenopausal 
status, while IMT decreased with increasing HDL-c and alcohol use.   
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In the multivariable models adjusted for age, site, race, HDL-c, LDL-c, SBP, glucose, 
waist circumference and smoking, the effect of HDL-c significantly varied by menopausal 
status (interaction p-value = 0.01 for high and moderate AC).  To better visualize the 
interactions, the models were reparameterized to the following: subclinical measure = 
Menopausal Status + Effect for HDL-c for Pre/EP women + Effect for HDL-c for LP/Post 
women + Covariates (Figure 3.1).  For every 1 mg/dL increase in HDL-c the odds of high 
AC among Pre/EP women was decreased by 2% (OR = 0.98, 95% CI = 0.94, 1.02) while 
the odds for LP/Post women was increased by 5% (OR = 1.05, 95% CI = 1.01, 1.09).  For 
the carotid plaque model, the interaction p-value was 0.08 after adjustment for age, site, 
race, HDL-c and LDL-c.  Although not significant, a similar pattern of HDL-c being protective 
for Pre/EP women, but not for LP/Post women was seen in the reparameterized model (OR 
= 0.97, 95% CI = 0.94, >1.00 vs. OR = 1.01 95% CI = 0.98, 1.03).  After adjusting for age, 
site, race, HDL-c, LDL-c, SBP and waist circumference, the interaction in the IMT model 
reached statistical significance (p-value = 0.03).  Reparameterization of the adjusted model 
showed that HDL-c was negatively associated with IMT in Pre/EP women, but positively 
associated in LP/Post women (not significant).  For every 1 mg/dL increase in HDL-c there 
was an associated 0.001 mm decrease in IMT for Pre/EP women (-0.002, -0.0002) and a 
0.0002 mm increase for LP/Post women (-0.0006, 0.0009). 
The interaction between LDL-c and menopausal status was tested, but did not reach 
statistical significance for any of the three subclinical measures (data not shown). However, 
in multivariable analyses stratified by menopausal status, the odds ratio of high AC 
associated with a 1 mg/dL increase in LDL-c was 1.02 (<1.00, 1.04) for Pre/EP women and 
1.03 (1.01, 1.05) for LP/Post women.  An odds ratio associated with LDL-c of 1.00 (0.99, 
1.01) and 1.02 (>1.00, 1.03) for Pre/EP and LP/Post women respectively was observed for 
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any carotid plaque.  The β coefficient estimate for IMT was -.00005 (-.0004, .0003) among 
Pre/EP women and .0003 (-.0001, .0007) among LP/Post women for LDL-c.   
Similar analyses were conducted with coronary artery calcification as an outcome.  
However, HDL-c was protective for Pre/EP and LP/Post women alike (results not shown). 
 To explore lipoprotein profile difference by menopausal status, the lipoprotein NMR 
spectroscopy data for a small sub sample of Pittsburgh women (n = 19 for Pre/EP and n = 
34 for LP/Post) was used.  LP/Post women had more small HDL-p, more total HDL-p and a 
smaller HDL particle size on average (Table 3.3).  Large HDL-p concentrations were lower 
in LP/Post women, however this was not significant.  Finally, LP/Post women had 
significantly more total LDL-p than Pre/EP women.  
 
3.5 DISCUSSION 
 
This study demonstrates that the potency of lipids as CVD risk factors changes from 
premenopause to postmenopause.  Statistically significant interactions between 
menopausal status and HDL-c were seen for AC and IMT, while the interaction for carotid 
plaque was borderline.  Among LP/Post women, HDL-c appeared to lose its protective 
effect against subclinical CVD measures.  These results are in accord with Fan et al. who 
report that the protective effects of HDL-c on IMT may diminish around the age of 
menopause 13.  This analysis demonstrated positive associations between HDL-c and AC, 
any carotid plaque and IMT in LP/Post women after adjustments for traditional risk factors; 
where as HDL-c had a traditionally protective effect in Pre/EP women.  For LDL-c, there 
was a trend for a stronger association with subclinical measurements among LP/Post 
women; however this interaction did not reach statistical significance.  
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The traditional protective effect of HDL-c is exerted through reverse cholesterol 
transport, inhibition of LDL-c oxidation, decreased adhesion molecule expression and 
increased endothelial function 32-35.  In men, this protective effect is maintained 
longitudinally, suggesting the phenomenon observed in this analysis among LP/Post 
women is most likely not due to age and corresponds to changes due to the menopausal 
transition 13.  Additional evidence of a detrimental effect of HDL-c in women comes from the 
EUROSTROKE study, a collaboration between several large European cohort studies.  This 
study reported that among women pooled from the Novosibirsk and Rotterdam cohorts, 
higher HDL-c was associated with increased odds of stroke 36.  The average age of the 
cohorts were 51.6 and 72.8 years respectively; therefore these effects were seen among 
women who have recently transitioned through menopause and those who have been 
postmenopausal for years. 
Early studies report substantial rises in HDL-c with the menopausal transition.  Kim 
et al. and Do et al. explained that these studies, showing increases in HDL-c with the 
transition, are not accounting for the rise due to age.  The majority of researchers agree 
there is little net change in HDL-c when age is accounted for appropriately 8, 10, 12, 37.  A 
moderately higher HDL-c was observed in LP/Post compared to Pre/EP women in this 
analysis; however, this difference disappears once adjusted for age.  
The change in risk association between HDL-c and the menopausal transition may 
be explained by compositional changes in HDL-c lipoproteins.  Conventional methods of 
measuring HDL-c only reflect the concentration of cholesterol and not the HDL 
concentration 38.  The lipoprotein particles are believed to provide more information in 
predicting CHD 39.  Using NMR spectroscopy to capture lipoprotein particle concentrations, 
it has been shown that small HDL-p are less protective than the large HDL-p.  The 
traditional protective effect of HDL-c on CVD is mostly due to the large HDL-p 34, 40.  In the 
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Framingham Offspring Study and Milwaukee Cardiovascular Data Registry, having more 
small HDL-p were associated with higher odds of having coronary heart disease 28,34, 35, 41.  
However, these observations between HDL-c lipoproteins and CVD focused primarily on 
men, diabetics or drug therapies. 
A recent study exploring the relationship between HDL-c lipoproteins and the risk of 
CHD in postmenopausal women found no association with HDL-c, however, when the 
lipoprotein sub fractions were examined a negative association with large HDL-p and a 
positive association with small HDL-p was determined 39.  Similar results were obtained in 
Women’s Health Study for large HDL-p, but small HDL-p was not significant, however, this 
sample was a mixture of pre and postmenopausal women 42.  The small sub sample of 
NMR spectroscopy data available for Pittsburgh women in SWAN Heart showed that 
LP/Post women had more small HDL-p and smaller HDL particle size on average compared 
to Pre/EP women.  This lipoprotein subclass profile could potentially explain the loss of 
HDL-c protection observed in this analysis.  Another study found similar results where 
postmenopausal women had significantly more small HDL-p and fewer large HDL-p 
compared to premenopausal women 43.  The Healthy Women Study saw a significant 
protective association between coronary calcification and large HDL-p and HDL particle size 
in postmenopausal women, whereas small HDL-p were not correlated with coronary 
calcium 44.  In addition, postmenopausal women with aortic or coronary calcification had 
lower large HDL-p and higher small HDL-p 45.  It has been reported that increased levels of 
small HDL-p and smaller HDL particle size were correlated with thicker IMT measures of 
Finnish men and women 46. 
One potential mechanism responsible for these lipoprotein profile changes is 
enzymatic activity.  Large HDL-p are converted to small HDL-p by increased hepatic lipase 
47.  It is shown that estrogen inhibits this enzyme; therefore decreases in estrogen with 
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menopause would lead to a higher ratio of small HDL-p to large HDL-p.  In support of this 
theory, postmenopausal women have been found to have higher hepatic lipase activity that 
covaried inversely with large HDL-p.  Although not statistically significant, LP/Post women in 
this SWAN Heart analysis had larger waist circumference compared to Pre/EP women.  
This rise in central adiposity, most likely due to chronological aging, could account for 
additional increases in hepatic lipase activity leading to more small HDL-p.  One study 
found intra-abdominal fat to be positively associated with hepatic lipase activity in obese 
women 48. 
In addition to increasing hepatic lipase, decreased estrogen hinders several 
protective vascular mechanisms.  Estrogen is believed to accelerate reendothelialization in 
the face of vascular injury thereby inhibiting smooth muscle proliferation and subsequently 
medial thickening 49.  Vascular tone is maintained by estrogen through several pathways, 
including nitric oxide and prostacyclin 4.  Therefore, decreased estrogen following the 
menopausal transition leaves the vasculature vulnerable to CVD risk factors.  SWAN Heart, 
has previously shown that lower estrogens are directly related to larger carotid arterial 
diameter 30.  Larger vessel diameters lead to less ability to compensate for hemodynamic 
changes due to blood pressure or arterial wall thickening and thus leave the vessel more 
vulnerable 30, 50.  Indirect effects of estrogen on the vasculature include maintenance of 
cardioprotective lipid profiles, decreased coagulation and reduced LDL-c oxidation 3. 
Other lipoprotein profile changes include a significant increase in LDL-c as women 
transition through menopause 8-11.  The difference in LDL-c was statistically significant in the 
LP/Post compared to Pre/EP women.  Menopausal status did not significantly modify the 
contribution of LDL-c on subclinical measures, but a similar pattern of LDL-c as a stronger 
risk factor among postmenopausal women was suggested for all three subclinical 
measures.  Given the moderate sample size in this analysis, further studies examining this 
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possibility are indicated.  The NMR data in this analysis showed that LP/Post women have 
higher total LDL-p. This coincides with the literature that suggests the quantity of LDL-p, 
rather than the particle size is a stronger predictor of CHD risk 42.  Thus it is possible that 
the potency of LDL-c as a risk factor does increase after the transition.  
This analysis is comprehensive because we were able to analyze the contribution of 
menopausal status, HDL-c and LDL-c and lipoprotein subclasses in the same study.  A 
positive association with HDL-c among LP/Post women was consistently observed across 3 
subclinical measures.  The NMR data provides initial evidence that supports the potential 
mechanism of lipoprotein compositional changes being responsible for this association.  
This analysis is cross sectional, and thus a causal relationship between menopause status 
and HDL changes cannot be proven.  However, acute changes in calcification, carotid 
plaque and IMT have been reported previously, supporting the potential for subclinical 
disease development over the menopausal transition 36, 51-53.  Premature and early 
menopause ranged from 1 - 1.4% and 2.9 - 3.7% respectively, in SWAN Caucasian and 
African American women 54.  It is plausible that the lipid changes attributed to the 
menopausal transition may instead be explained by altered lipid patterns due to premature 
and early menopause 55.  Despite the modest sample size for detecting interactions, the 
HDL-c by menopausal status interaction was significant for AC and IMT, suggesting 
differences effect by menopausal status.  The borderline and non-significance observed for 
carotid plaque and LDL-c require larger sample sizes for confirmation.  The protective effect 
of HDL-c to coronary artery calcification among LP/Post women could be due to the low 
amount of plaque detected in the SWAN Heart population (2.4%) 29.  A loss of HDL-c 
protection for coronary artery calcification might be observed in a population with more 
extensive disease and therefore further studies need to be conducted in this area.  Lastly, 
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since all participants did not have NMR data, lipoproteins could not be use in the regression 
models. 
In conclusion, the protective effect of HDL-c is reduced among postmenopausal 
women most likely related to changes in the lipid profile seen with the menopausal 
transition.  This, in addition to a more vulnerable vessel caused by age, decreased estrogen 
and adipose tissue redistribution, may partially explain the increased CVD risk seen after 
menopause.  Future studies evaluating lipid profiles longitudinally through the menopause 
transition are needed.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
3.6 ACKNOWLEDGEMENTS 
 
We thank the study staff at each site and all the women who participated in SWAN. Clinical 
Centers:  University of Michigan, Ann Arbor - MaryFran Sowers, PI; Massachusetts General 
Hospital, Boston, MA  - Robert Neer, PI 1994 - 1999; Joel Finkelstein, PI 1999- present; 
Rush University, Rush University Medical Center, Chicago, IL - Lynda Powell, PI 1994 – 
2009; Howard Kravitz, PI 2009; University of California, Davis/Kaiser - Ellen Gold, PI; 
University of California, Los Angeles - Gail Greendale, PI; University of Medicine and 
Dentistry - New Jersey Medical School, Newark –Gerson Weiss, PI 1994 – 2004;  Nanette 
Santoro, PI  2004 – present; and the University of Pittsburgh, Pittsburgh, PA - Karen 
Matthews, PI.  NIH Program Office:  National Institute on Aging, Bethesda, MD - Marcia Ory 
1994 – 2001; Sherry Sherman 1994 – present; National Institute of Nursing Research, 
Bethesda, MD – Program Officers.  Central Laboratory:  University of Michigan, Ann Arbor - 
Daniel McConnell  (Central Ligand Assay Satellite Services).  Coordinating Center:  New 
England Research Institutes, Watertown, MA - Sonja McKinlay, PI 1995 – 2001; University 
of Pittsburgh, Pittsburgh, PA – Kim Sutton-Tyrrell, PI  2001 – present.  Steering Committee: 
Chris Gallagher, Chair  and Susan Johnson, Chair.  Funding Sources: The Study of 
Women's Health Across the Nation (SWAN) has grant support from the National Institutes 
of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute 
of Nursing Research (NINR) and the NIH Office of Research on Women’s Health (ORWH) 
(Grants NR004061; AG012505, AG012535, AG012531, AG012539, AG012546, AG012553, 
AG012554, AG012495).  SWAN Heart was supported by grants from the NIH through the 
National Heart, Lung, and Blood Institute (HL065581, HL065591). The content of this 
manuscript is solely the responsibility of the authors and does not necessarily represent the 
official views of the NIA, NINR, ORWH or the NIH. 
34 
 
3.7 TABLES AND FIGURES 
 
 
 
Table 3.1 Participant characteristics by menopausal status 
 
 
Values are presented as mean (SD); p-values generated with t-test  
† Values are presented as % (n); p-values generated with chi-square test 
* Non-normally distributed; values presented as median (IQR); p-values generated with t-test with log of glucose 
 
 
 
 
 
 
 
 
 
Characteristic n Total Pre/EP  n=316 
LP/Post 
n=224 p-value 
Age 
Adjusted 
p-value 
Age (years) 540 50.2 (2.9) 48.9 (2.2) 52.1 (2.7) < .0001 ─ 
African American (%) † 540 38.7 (209) 36.1 (114) 42.4 (95) 0.14 0.31 
Alcohol (yes/no, %) † 537 61.6 (331) 61.5 (193) 61.9 (138) 0.92 0.50 
Smoker (ever regular, %) † 488 16.0 (78) 16.6 (47) 15.2 (31) 0.69 0.32 
HDL-c (mg/dL) 472 57.5 (15.0) 56.2 (13.8) 59.3 (16.4) 0.04 0.23 
LDL-c (mg/dL) 474 119.0 (32.8) 113.5 (28.7) 126.6 (36.5) < .0001 < .0001 
SBP (mmHg) 519 119.7 (16.7) 118.2 (16.3) 121.7 (17.0) 0.017 0.94 
Glucose (mg/dL) * 480 88 (83, 96) 87 (81, 95) 91 (84, 98) 0.0003 0.01 
Waist Circumference (cm) 518 89.2 (14.4) 88.3 (14.7) 90.5 (14.0) 0.089 0.69 
BMI (kg/m2) 518 29.4 (6.4) 29.1 (6.5) 29.7 (6.3) 0.35 0.85 
Aortic Calcification (%) † 
  None (0) 
  Moderate (1-74) 
  High (75 +) 
515 
 
 
 
 
30.3 (156) 
44.7 (230) 
25.0 (129) 
 
34.3 (104) 
44.9 (136) 
20.8 (63) 
 
24.5 (52) 
44.4 (94) 
31.1 (66) 
0.0096 
 
 
 
0.28 
 
 
 
Any Carotid Plaque (%) † 535 15.1 (81) 11.5 (36) 20.4 (45) 0.0047 0.04 
Intima Media Thickness (mm) 529 0.67 (0.1) 0.66 (0.1) 0.68 (0.1) 0.040 0.77 
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Table 3.2 Univariate associations between traditional CVD risk factors and subclinical measures 
 
 
 
 
 
 
Risk Factor 
Subclinical measure 
Aortic Calcification 
n = 515 
 
Any Carotid Plaque 
n = 535 
OR (95% CI) 
 
Carotid IMT (mm) 
n = 529 
β Estimates (95% CI) Moderate AC 
OR (95% CI) 
High AC 
OR (95% CI) 
Age (years) 1.09 (1.01, 1.17) † 1.18 (1.09, 1.28) * 1.09 (>1.00, 1.18) † 0.006 (0.003, 0.009) * 
African American (%) 1.90 (1.23, 2.93) * 1.61 (0.98, 2.64) 0.94 (0.58, 1.53) 0.033 (0.016, 0.050) * 
Alcohol (yes/no, %) 0.69 (0.44, 1.06) 0.53 (0.32, 0.86) * 0.62 (0.38, 0.99) † -0.033 (-0.051, -0.017) * 
Smoker (ever regular, %) 1.00 (0.51, 1.96) 3.05 (1.58, 5.88) * 1.03 (0.52, 2.01) -0.021 (-0.044, 0.002) 
HDL-c (mg/dL) 0.97 (0.95, 0.98) * 0.97 (0.95, 0.98) * 0.99 (0.97, 1.01) -0.001 (-0.002, -0.0005) * 
LDL-c (mg/dL) 1.02 (1.01, 1.03) * 1.02 (1.01, 1.03) * 1.01 (>1.00, 1.02) * 0.0004 (0.0002, 0.001) * 
SBP (mmHg) 1.03 (1.01, 1.04) * 1.04 (1.03, 1.06) * 1.00 (0.99, 1.02) 0.001 (0.001, 0.002) * 
Glucose (mg/dL) # 1.06 (1.04, 1.08) * 1.06 (1.04, 1.09) * 1.00 (0.99, 1.01) 0.115 (0.062, 0.168) * 
Waist Circumference (cm) 1.14 (1.11, 1.17) * 1.18 (1.14, 1.22) * 1.01 (0.99, 1.02) 0.002 (0.002, 0.003) * 
Late Peri/Postmenopausal 1.38 (0.91, 2.11) 2.10 (1.30, 3.39) * 1.97 (1.23, 3.18) * 0.018 (0.001, 0.035) † 
 
Values are odds ratios (95% CI) for AC and carotid plaque and β Estimates (95% CI) for IMT. 
Reference value for both moderate and high AC was no calcification. 
# Glucose was log transformed in linear regression model for carotid IMT 
* < 0.01, † <0.05 
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Figure 3.1 Multivariable association between HDL-c and subclinical measures 
 
High AC - values are OR (95% CI) of high AC for HDL-c; adjusted for age, site, race, LDL-c, SBP, glucose, waist circumference and smoking. 
Any Carotid Plaque - values are odds ratios (95% CI) of carotid plaque for HDL-c; adjusted for age, site, race and LDL-c. 
Carotid IMT - values are β coefficient estimates (95% CI) of IMT for HDL-c; adjusted for age, site, race, LDL-c, SBP and waist circumference. 
* < 0.01, † <0.05 for Pre/EP versus LP/Post 
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Table 3.3 Lipoprotein levels by menopausal status for Pittsburgh SWAN Heart sub 
sample 
 
 
 
Values are presented as mean (SD); p-values generated with t-test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipid Variable Pre/EP (n=19) LP/Post (n=34) p-value 
HDL-c (mg/dL) 49.1 (15.0) 49.3 (14.0) 0.97 
Small HDL Particles (µmol/L) 21.6 (5.7) 26.6 (5.7) 0.0035 
Large HDL Particles (µmol/L) 6.7 (2.9) 6.1 (3.1) 0.49 
Total HDL Particles (µmol/L) 28.3 (6.4) 32.7 (7.6) 0.037 
HDL Particle Size (nm) 9.4 (0.5) 9.1 (0.4) 0.0078 
IDL-p (nmol/L) 41.9 (35.5) 70.9 (52.7) 0.037 
Small LDL Particles (nmol/L) 478.2 (247.1) 620.5 (351.7) 0.13 
Large LDL Particles (nmol/L) 575.4 (193.7) 620.3 (227.1) 0.47 
Total LDL Particles (nmol/L) 1095.6 (189.3) 1311.6 (325) 0.0036 
LDL Particle Size (nm) 21.6 (0.5) 21.5 (0.7) 0.50 
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4.1 ABSTRACT 
 
Background: Education is protective against risk factors and incident cardiovascular disease 
(CVD).  The protective effect of education for CVD has suggested to be stronger among 
females.  The association between education and subclinical CVD was assessed for males 
and females from the Tobago Family Health Study.  Differences in CVD risk factors by 
education were evaluated as potential mechanism for gender differences in the education-
subclinical CVD relationship.  Methods:  A community-based sample of Afro-Caribbean 
males and females were evaluated for intima media thickness (IMT), adventitial diameter 
(AD) and lumen diameter (LD).  Education, age, waist circumference, SBP, HDL-c, LDL-c 
and other traditional CVD risk factors were collected.  Results: The average age was 43.7 
years and ranged from 18 to 86 years.  More females had ≥ secondary education compared 
to males (52% versus 34%, p-value = 0.0093).  Mean IMT, AD and LD were higher among 
males.  The interaction between education and gender was significant for AD and LD.  The 
adjusted mean AD and LD were lower among females that had ≥ secondary education 
compared to females with < secondary education (AD: 6.94 vs. 7.29 mm, p-value = 0.0051 
and LD: 5.51 vs. 5.90 mm, p-value = 0.0010).  There was no significant difference observed 
for males.  Females with ≥ secondary education also had lower age adjusted SBP 
compared to females < secondary education.  Males with ≥ secondary education had lower 
HDL-c and higher LDL-c compared to males < secondary education.  Conclusion: Gender 
differences in the association between education and subclinical CVD are evident in a 
Tobago population.  Educational differences in SBP for females and lipids for males may 
potentially explain some of the gender difference in the education-subclinical CVD 
relationship.   
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4.2 INTRODUCTION 
 
It is well established that education is inversely related to health in developed countries.  
Those with lower education have higher rates of CVD risk factors such as obesity, 
hypertension and atherogenic lipid profiles 1.  In addition, lower education is associated with 
higher risk of all cause-mortality, cerebrovascular disease and cardiovascular disease 
(CVD).  The inverse association observed between education and health outcomes has 
been shown to vary by gender.  Higher education and other measures of social position are 
protective for all cause mortality, with several studies showing a steeper gradient among 
males 2-7.  On the other hand, the protective effect of education and social position for CVD 
is steeper among females 1-3, 8-12.   
The relationship between traditional CVD risk factors and education varies by 
gender.  In developed countries, education tends to be protective against hypertension and 
obesity among females, whereas a significant association is not always evident for males 13.  
The gender difference in the education-SBP relationship is even more striking in developing 
countries.  Males in the Caribbean have been shown to have a direct association between 
education and SBP 14, 15.          
In 2004 approximately 25% of deaths in Trinidad and Tobago were due to CVD, 
making it the leading cause of death 16.  Intima media thickness (IMT) and adventitial and 
lumen diameter (AD and LD, respectively) are markers of early atherosclerosis and vascular 
remodeling 17-20.  Increases in IMT, AD and LD are associated with CVD risk factors and 
clinical outcomes such as myocardial infarction and stroke, making these measures quality 
subclinical markers for CVD 17, 21-24.  
 Few studies have examined the association between education and CVD by gender 
in developing countries, and no study to date has evaluated this relationship in a population 
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of African descent.  Using a community-based population of Afro-Caribbean males and 
females from the Tobago Family Health Study, the gender difference in the education-
subclinical CVD relationship was assessed.  Potential mechanisms explaining this 
relationship was further evaluated by exploring education differences in traditional CVD risk 
factors for males and females. 
 
4.3 METHODS 
 
4.3.1 Study Population 
 
The Tobago Family Health Study began recruitment in 2003 on the Caribbean Island of 
Tobago.  Study design and recruitment have been previously described 25.  The purpose of 
this study was to assess the role of inheritance, lifestyle and body composition in the 
etiology of chronic disease, including diabetes, obesity and CVD.  A total of 471 individual 
participants were recruited from 8 large multi-generational families of Afro-Caribbean 
ancestry.  To be eligible for the Tobago Family Health Study, a proband had to be Afro-
Caribbean (reported that all 4 of grandparents were Afro-Caribbean), have a spouse willing 
to participate in the study and at least 6 living offspring and/or siblings (≥ 18 years of age) 
residing in Tobago.  In order to obtain a community-based sample, representative of the 
island of Tobago, no health status eligibility criteria were defined.  An ancillary study to the 
Tobago Family Health Study, invited participants back for an ultrasound scan of their carotid 
arteries.  Of the 471 participants originally recruited for the parent study, 415 returned for an 
ultrasound scan.  To date, 255 of these images have been read and were available for this 
analysis.   
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 The Tobago Ministry of Health and University of Pittsburgh institutional review 
boards approved research protocols for the Tobago Family Health study.  All participants 
provided written informed consent prior to enrollment. 
 
4.3.2 Subclinical Measures 
 
All Tobago Family Health Study participants were invited back for a B-mode carotid 
ultrasound scan conducted between May 2007 and November 2008.  The common carotid 
artery (CCA) was imaged using an Acuson Cypress portable ultrasound machine (Siemens 
Medical Solutions, Malvern, PA).  Images were taken from the near and far walls of the 
distal CCA (one centimeter proximal to the carotid bulb).  Intima media thickness (IMT) 
measures were obtained electronically using a semi-automated reading software (AMS 
system developed in Sweden by Dr. Thomas Gustavsson).  Lines were traced between the 
lumen-intima interface and the media-adventitia interface across the 1 cm segment.  The 
computer then generated one measurement for each pixel over this area, for a total of about 
140 measures. The mean of the near and far wall IMT measurements from the left and right 
CCA comprises the average IMT.  Diameter measurements were derived from the same 1 
cm CCA segment.  Specifically, the CCA inter-adventitial diameter was measured as the 
average distances between the adventitial-medial interface on the near wall and the medial-
adventitial interface on the far wall.  Similarly, the CCA intra-lumen diameter was measured 
using the two lumen-intima interfaces.  Inter-sonographer reproducibility was conducted on 
35 Tobago Family Health Study participants.  The intraclass correlation (ICC) was 0.97 for 
average IMT and 0.95 for average AD.  All images were read centrally at the Department of 
Epidemiology’s Ultrasound Research Laboratory (University of Pittsburgh, Pittsburgh, PA).  
Inter-reader ICC was 0.99 for IMT and AD.   
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4.3.3 Education Measure 
 
Participants were asked what was their highest grade or level of schooling completed.  
Categories included: no formal education, primary (age 5 – 11 years), secondary – O level 
(age 11 – 16 years), secondary – A level (16 – 18 years), technical vocational training, 
some university or associate degree, university graduate (4 or 5 year program), master’s 
degree (or other post-graduate training) or doctoral degree (MD, MBBS, PhD, EDD, DVM, 
DDS, JD). 
 
4.3.4 Covariates 
 
Trained and certified clinical staff conducted standardized interviewer-administered 
questionnaires.  Race was self-defined by the participant in conjunction with a detailed 
ascertainment of the ethnic origin of their parents and grandparents.  According to recent 
census data, 97% of the island of Tobago is of West African origin, therefore, this analysis 
was limited to those who reported Afro-Caribbean race (n=232, 91% of those participants 
with a carotid scan) 26.  Participants were asked how many alcoholic beverages (beer, wine 
or liquor) they consumed on a weekly basis.  Smoking status was defined as ever smoked 
(> 100 cigarettes in a lifetime) or never smoked.  Physical activity was reported as the 
number of minutes walked per week.  Marital status was categorized as 1) married/ or living 
as married or 2) widowed, divorced, separated or never married.   
 Blood pressure was measured three times in the right arm following a 5 minute rest 
period using the Omron HEM-705 automatic monitor. An average of the last two readings 
was taken.  Weight (measured to the nearest 0.1 kg, wearing indoor clothing, but no shoes) 
was assessed using a balance beam scale and standing height (measured to the nearest 
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0.1 cm, without shoes) with a wall-mounted stadiometer.  An average of two readings was 
used for final weight and height measurements.  Body mass index (BMI) was calculated by 
dividing weight (kg) by height squared (m2).  An inelastic tape measure around the 
abdomen, at the point of the umbilicus, was used to determine waist circumference (cm). 
Venipuncture blood samples were collected on participants who had been fasting for 
12 hours.  All biochemical assays were performed in the Heinz Nutrition Laboratory at the 
University of Pittsburgh.  Serum glucose, triglycerides, total cholesterol and HDL were 
quantitatively determined utilizing enzymatic reactions 27-29.  LDL-c was calculated indirectly 
using the Friedewald equation 30.  CRP was measured by a commercial calorimetric 
competitive enzyme-linked immunosorbent assay (from Diagnostic Systems Laboratories, 
Inc).  
 
4.3.5 Statistical Analysis 
 
The distribution of each continuous variable was examined and log transformed if needed to 
approximate normality.  Triglycerides, glucose and CRP were log transformed; however, 
medians (IQR) are presented in Table 1 for descriptive purposes. All remaining variables 
met the guidelines for normality and were treated as continuous.  Highest level of completed 
education was dichotomized as < secondary education and ≥ secondary education.  Alcohol 
was categorized into zero drinks or ≥ one drink per week; physical activity into ≤ 30 minutes 
or > 30 minutes of walking per week; and marital status into married or not married.  These 
variables were collapsed into these cutoffs to maintain adequate sample size in each 
category.  Physical activity was tested in univariate models, but was not retained in 
multivariable modeling due to large number of missing values (n=66).  Two sample t-test 
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and chi-square test were utilized to compare participant characteristics between males and 
females.    
Univariate and multivariable linear regression were used to assess the association 
between traditional CVD risk factors and IMT, AD and LD.  Stepwise regression selection 
was used to evaluate the inclusion of traditional CVD risk factors in the multivariable linear 
regression models.  Age, height, gender and education were variables of interest and 
therefore kept in the final models.  Waist circumference was chosen in multivariable models 
because it explained more of the variation compared to BMI.  Models repeated using BMI 
showed similar results to those including waist circumference.  The interaction between 
education and gender was tested in multivariable models with and without adjustments for 
other covariates.  Further exploration of the education interaction was done using a 
reparameterized model to include the effects of education among males and females in a 
single multivariable model.  Adjusted least squares means were obtained from generalized 
linear models.  Statistical analyses were completed with SAS 9.1. Two-sided p-values ≤ 
0.05 were considered statistically significant. 
 
4.4 RESULTS 
 
Of the 232 Tobago Family Health Study participants used in this analysis, 152 (66%) were 
female (Table 1).  The average age was 43.7 years (range 18 to 86).  Forty-six percent of 
participants had ≥ secondary education, with females having a higher percentage than 
males (52% versus 34%, p-value = 0.0093).  On average, males drank more alcohol, 
smoked more cigarettes, were more likely to be married and had higher blood pressures 
then females.  Mean LDL-c, CRP and BMI were higher among females. Mean IMT, AD and 
LD were higher among males. 
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Univariate analyses were conducted to determine which CVD risk factors were 
associated with subclinical CVD (Table 2).  Having ≥ secondary education was associated 
with lower mean IMT, AD and LD in univariate analyses, whereas SBP and waist were 
associated with higher means of all three subclinical measures.  Mean IMT and AD were 
positively associated with age, marital status, DBP, LDL-c and glucose.  Female gender 
was associated with lower mean AD and LD in unadjusted models.  Alcohol, physical 
activity and CRP were not associated with any of the subclinical measures. 
Multivariable models for subclinical CVD risk factors included age, height, gender, 
education and other CVD risk factors that remained significant (Table 3).  Having ≥ 
secondary education continued to be protective only for LD in adjusted models.  Waist 
circumference was the only risk factor that remained significant in multivariable analysis for 
all three outcomes.  Female gender remained independently associated only with mean IMT 
in multivariable modeling.   
Interactions between gender and SBP, waist circumference and education were 
tested for all three subclinical measures (Table 4).  For AD and LD, the gender and 
education interaction was significant (unadjusted p-value = 0.0066 and 0.0014, 
respectively).  The interaction remained significant for LD and borderline for AD after 
adjusting for age, SBP, waist circumference and height (adjusted p-value = 0.021 and 
0.061, respectively).  To demonstrate this interaction further, adjusted mean AD and LD are 
shown in Figure 1.  AD and LD means were significantly lower for females with ≥ secondary 
education compared to those with < secondary education (AD: 6.94 vs. 7.29 mm, p-value = 
0.0051 and LD: 5.51 vs. 5.90 mm, p-value = 0.0010).  These means were adjusted for age, 
SBP, height and waist circumference.  There were no significant differences between 
education levels for AD or LD among males.  No significant interactions were found for IMT. 
 52 
Finally, age adjusted CVD risk factors were examined by education level for males 
and females (Figure 2).  Waist circumference did not vary by education for males or 
females.  Mean SBP was significantly higher among females with < secondary education 
than ≥ secondary education (126.0 vs. 115.7 mmHg, p-value = 0.0048).  Adjusting for waist 
circumference did not attenuate the difference (data not shown).  The lipid profile was worse 
for males with ≥ secondary education than < secondary education: lower HDL-c and higher 
LDL-c (34.9 vs. 45.0 mg/dL, p-value = 0.0025 and 136.4 vs. 117.7 mg/dL, p-value = 0.041, 
respectively).  Triglycerides, glucose, CRP, smoking and alcohol did not vary by education 
level (data not shown). 
 
4.5 DISCUSSION 
 
It was observed that the effect of education on subclinical CVD varied by gender; education 
was protective for females, but this pattern was not seen for males.  This interaction 
remained significant for LD and borderline for AD after adjustment for CVD risk factors.  
This was in accord with Rosvall et al. who demonstrated a significant inverse association 
with subclinical CVD for females, but not males after adjustment for CVD risk factors in a 
general population of adults 46 to 68 years of age from Sweden 9, 10.  When age adjusted 
CVD risk factors were evaluated by education for males and females from the Tobago 
population, some interesting trends were seen.  The only CVD risk factor that differed by 
education level for females was SBP, which was lower for those with a higher education.  
Interestingly, among males with ≥ secondary education, HDL-c was lower and LDL-c was 
higher compared to males with < secondary education.  These patterns in education 
differences by gender have been documented previously 13, 31-33.  In a population of males 
and females from Trinidad ages 24 to 89 years, an inverse association for education-SBP 
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was only observed among females 32.  Higher LDL-c and lower HDL-c have been observed 
among Chinese, Polish and Russian men with higher education levels 33. 
The association between education and incident CVD has been shown to vary by 
gender, with females having a stronger association than males 1-3, 12, 34.  In a population of 
adults from Finland, 35 to 64 years of age, females showed the largest education difference 
for CVD deaths 3.  Mackenbach et al. explored this gender difference in seven countries 
and observed a larger inequality in CVD mortality between low and high education levels for 
females in five of the countries 2.  Consistent with previous literature, both studies showed 
the opposite pattern for all-cause mortality, with males having a steep education-mortality 
gradient compared to females.  It has been argued that much of this gender difference in 
the education-CVD relationship can be explained by BMI 12.  In the Tobago population, the 
effect of education for AD and LD varied by gender, however, adjustment for waist 
circumference did not significantly attenuate this finding.  
Other markers of social position, neighborhood status and occupation, have shown 
similar gender differences seen for education-CVD relationship.  Females, ages 25 to 64 
years, from the Glasgow MONICA coronary event register, who lived in more deprived 
neighborhoods had higher rates of myocardial infarctions and coronary deaths compared to 
those in better neighborhoods 11.  This association was not as strong for males.  A large 
sample (n=12,000) representing the general population of the Netherlands showed a 
marked difference in CVD morbidity (angina, infarction and neurovascular incidence) by 
occupation for females only 8.  
Not all studies have shown a gender difference in the relationship between 
education and CVD.  NHANES I showed that for circulatory deaths, education was 
protective for males and females equally 35.  However, significantly more males died 
compared to females during the 20 year follow up.  Since females live longer than males, it 
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is plausible that not enough circulatory events were observed among females to see a 
gender difference in the association between education and mortality.  
Similar to incident CVD, a stronger association between education and subclinical 
CVD has been observed among females.  Thicker IMT and more carotid stenosis were 
seen among females, from a subcohort of the population-based Malmö Diet and Cancer 
Study, with lower education or lower occupational status after adjustment for CVD risk 
factors 9.  This observation was not apparent for males.   In the same subcohort, life-course 
occupation, a combination of parental and adulthood occupation, was associated with 
carotid stenosis for females only 10.  The association between neighborhood poverty, 
childhood socioeconomic position or adult socioeconomic positioning (a summary score for 
income, education and wealth) and carotid IMT also varied by gender 36.  All three 
socioeconomic positioning measures were inversely associated with IMT among females.  
There are several explanations for the greater protective effect of education on 
subclinical CVD among females compared to males.  Females depend on education more 
for health than males 37.  A higher education results in higher expectations of health and 
better ability to estimate risk.  Results from the NHANES I study showed that education 
modified the contribution of cardiovascular risk factors to self-rated health for females; 
highly educated females had higher odds of poor self-reported health among those with 
high glycosylated hemoglobin or high cholesterol 38.  Education was not related to self-
reported health among males.  Females with lower education have been shown to have 
higher rates of psychological disadvantages including: low income, depression, single 
parenting and unemployment 12.  Therefore, poorer health among low educated females 
may be due to higher psychological stressors compared to males with low education.     
Delayed gratification is another factor that contributes to the protective effect of 
education for females.  The higher rate of college education among females in the US is 
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partially due to personal and family related returns 39.  These female-favorable trends are in 
the form of income, marital returns and insurance against poverty.  More females in the 
Tobago population had ≥ secondary education compared to males.  Gender disparities in 
education attainment are reversing in Latin America and the Caribbean, with female 
education rates now exceeding that of males 40.  In 2005 the ratio of females to males 
completing primary education was 1.09 on the islands of Trinidad and Tobago.  It is 
plausible that personal and family returns may account for the higher rate of schooling 
among females, and the larger dependence of education for health among females may 
contribute to the protective effect of education on subclinical CVD observed in the Tobago 
population.     
Currently, the Republic of Trinidad and Tobago is a high-income developing nation: 
the wealthiest independent country in the Caribbean 41.  The economic transition 
experienced by developing countries alters patterns in CVD risk factors.  The current 
transition has led to increased obesity and non-communicable diseases among developing 
countries 42.  This transition is a result of urbanization and globalization, which increases 
food production, mass media advertisements, supermarkets, technology and transportation 
42, 43.  These changes lead to a rapid shift to diets high in fat, sugar and salt.  These types of 
foods tend to be high energy dense and low cost 44.  Decreased energy expenditure due to 
less labor intensives occupations and more television watching also aid in increased CVD 
risk.  Initially with economic prosperity, increased CVD risk occurs among high social 
classes, but with time this reverses and lower social classes share this increased risk 13. 
It is possible that the way in which CVD manifests itself varies by gender.  Risk 
factors may play diverse roles and have varying potencies in the pathogenesis of 
atherosclerotic changes for males and females 4.  Gender differences in CVD risk factors by 
education level may in part explain the difference in education-CVD relationship observed 
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for males and females 2.  Evaluation of education differences for Tobago males and females 
revealed varying effects of education on SBP, HDL-c and LDL-c, but not waist 
circumference.  In addition to the effect of education on risk factors, the economic transition 
may be responsible for some of the observed differences in risk factors. 
The relationship between education and SBP varies by gender and varies by the 
economic status of the country where the population was sampled.  The protective effect of 
education on SBP for females tends to be independent of age, but largely explained by BMI 
for both developed and developing countries; however, adjustments for waist circumference 
in the Tobago population did not explain the difference 13.  The education gradient in SBP 
was further explained with salt intake and physical activity among a population of Trinidad 
females 32.  It is plausible that these two behaviors are influenced by education and the 
effect of education on salt intake and physical activity varies by gender.  Colhoun el at. 
reviewed the socioeconomic status-blood pressure relationship in 57 studies from 
developed and 13 from developing countries 13.  In developed countries, an inverse 
association was more consistent with females.  Similar to developed countries, education 
was inversely related to SBP for females and not significantly related for males among a 
population of Trinidadians 32.  The direct association observed for males in developing 
countries such as Jamaica and St. Vincent, may reflect the low income economic status of 
the country and likely represents an earlier time point in the economic transition 14, 15.  The 
10 mmHg difference seen between education levels in the Tobago females is large 
compared to the usual difference of 2 to 3 mmHg reported by Colhoun el at., however, the 
NHANES II study observed a difference of 10 mmHg among females 13 45.  
The association between lipids and schooling varies across countries based on their 
societal economic development more for males.  Among US white males there was an 
inverse association between education and LDL-c and a direct association with HDL-c 33.  
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When US black males and males from China, Israel, Poland and Russia were pooled 
together, the opposite was observed: direct relationship with LDL-c and inverse relationship 
with HDL-c.  In Jackson, Mississippi, a poor, southern urban community that may parallel a 
developing country, males who lived in “poorer” neighborhoods who had higher individual 
socioeconomic status had higher serum cholesterol, while those who lived in “richer” 
neighborhoods had lower cholesterol with higher socioeconomic status 31.  It is plausible 
that males in developing countries, who have more education and or resources, tend to eat 
diets high in fat, whereas educated females avoid such diets.  The effect of physical activity 
and alcohol consumption on lipid profiles for males and females may vary by education.  
However, alcohol consumption did not vary by education level for males or females in the 
Tobago population.       
Although a strong predictor of subclinical CVD, waist circumference did not vary by 
education for the Tobago population.  A strong inverse association between education and 
obesity has been observed among females of developed countries whereas the association 
among males is nonsignificant 46.  Obesity is positively associated with higher 
socioeconomic status in low-income developing countries, but as the country becomes 
economically developed the relationship reversed with higher socioeconomic status being 
protective against obesity 47.  Those in the transition have a mixed picture.  Therefore, the 
nonsignificant difference for obesity by education level seen in the Tobago population for 
may be explained by the economic transition.  Females weighted significantly more than 
males in the Tobago population.  Therefore, the protective effect of education may been 
ameliorated among females due to their high rates of obesity 43. 
A few aspects of this study need to be considered when interpreting the results.  
First, the Tobago Family Health Study was cross-sectional, however, education begins in 
childhood and continues on into early adulthood.  It is unlikely that subclinical CVD 
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influences the level of education attained and therefore reverse causality is unlikely.  The 
association between education and subclinical CVD for males could have occurred due to a 
type II error.  Low educated males may have died of competing risks or were too sick to 
participant in the study.  Therefore the education-subclinical CVD relationship needs to be 
reevaluated in a larger sample of males and females.  The higher subclinical CVD among 
males compared to females may account in part for the observed gender difference.  
Specifically, a smaller effect of education on subclinical CVD is plausible with a higher 
prevalence of disease.   Another consideration is during vascular remodeling, AD can mask 
IMT changes 48.  Given the large age range and young average age of the study population 
(44 years), it is possible that there simply was not enough IMT change to observed gender 
differences in the education-IMT relationship.  Exploration of IMT may need to be conducted 
in a sample of older adults.  Given the wide age range it is also possible that a cohort effect 
masked the results.  The education older adults received may vary compared to younger 
adults.  Future analyses with a larger sample size should stratify the interaction by age 
categories 49.  Given the design of the Tobago Family Health study, 8 large multi-
generational families, observations are not independent; therefore, results may be biased.  
Lastly, there were several variables not collected in this study.  Previous literature has 
shown that income and education did explain additional variability between education and 
health outcomes and education was a stronger predictor compared to income or occupation 
50-54.  Dietary and psychosocial health data was not available and a large portion of the 
physical activity data was missing.  These factors could potentially further explain the 
mechanism linking education and subclinical CVD; therefore, residual confounding could be 
present. 
 In conclusion, gender differences in the association between education and 
subclinical CVD are evident in a Tobago population.  Educational differences in SBP were 
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evident for females, and waist circumference did not account for this pattern.  Additional 
research needs to be conducted to assess differences in dietary salt intake and physical 
activity.  A poorer lipid profile was observed among males with higher education.  Fat intake 
and physical activity could be plausible mechanisms for this pattern.  Educational 
differences in risk factors are further complicated by the economic transition of Tobago and 
the global impact of obesity.  Gender disparities in education are reversing in Trinidad and 
Tobago.  As higher education rates increase with economic development, special interest 
needs to be taken in order to maintain gender parity in education to help reduce CVD.  Early 
education should include healthy lifestyles messages to encourage such behaviors in 
childhood.  
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4.6 TABLES AND FIGURES FOR CHAPTER FOUR 
 
Table 4.1 Participant characteristics by gender. 
 
Values presented as mean (SD) or percents (n); p-values generated with t-test or chi-square test 
* Non-normally distributed; values presented as median (IQR); p-values generated with t-test for log of triglycerides, 
log of glucose or log of CRP  
 
 
 
 
 
 
 
 
 
Characteristic Total  (n = 232) 
Female  
(n = 152) 
Male  
(n = 80) p-value 
Age 
adjusted 
p-value 
Age (years) 43.7 (15.9) 43.6 (15.8) 44.0 (16.1) 0.87 ─ 
Education (≥ secondary) 45.5 (105) 51.7 (78) 33.8 (27) 0.0093 0.0037 
Alcohol (> 1 drink/wk) 36.4 (84) 25.2 (38) 57.5 (46) <0.0001 <0.0001 
Smoke (100+ cigs) 8.2 (19) 2.6 (4) 19.0 (15) <0.0001 <0.0001 
Walking (> 30 mins/wk) 45.8 (76) 43.8 (46) 49.2 (30) 0.51 0.46 
Married 44.6 (103) 40.1 (61) 53.2 (42) 0.059 0.045 
SBP (mmHg) 124.2 (24.2) 120.8 (25.2) 130.6 (21.0) 0.0041 0.0007 
DBP (mmHg) 76.5 (12.7) 75.5 (12.8) 78.5 (12.2) 0.093 0.064 
HDL (mg/dL) 40.0 (12.9) 39.3 (13.6) 41.6 (11.3) 0.23 0.24 
LDL (mg/dL) 133.5 (41.4) 137.8 (43.3) 124.8 (35.7) 0.034 0.028 
Triglycerides (mg/dL) * 76.0 (59, 103) 75.0 (59, 95) 79.0 (59, 108)  0.26 0.21 
Glucose (mg/dL) * 83.0 (76, 91) 83.0 (76, 93) 84.0 (76, 89)  0.35 0.33 
CRP (mg/dL) * 1.0 (0.4, 2.2) 1.3 (0.5, 3.6) 0.7 (0.3, 1.5)  <0.0001 <0.0001 
Height (cm) 170.3 (8.1) 166.8 (6.4) 176.3 (6.5) <0.0001 <0.0001 
BMI (kg/m2) 29.0 (6.7) 30.1 (7.4) 26.9 (4.6) <0.0001 0.0004 
Waist (cm) 90.7 (15.2) 90.7 (16.7) 90.7 (12.2) 0.98 0.98 
Mean IMT (mm) 0.72 (0.16) 0.71 (0.15) 0.75 (0.17) 0.070 0.030 
Mean AD (mm) 7.2 (0.7) 7.1 (0.7) 7.4 (0.7) 0.0012 0.0009 
Mean LD (mm) 5.8 (0.6) 5.7 (0.6) 6.0 (0.6) 0.0025 0.0026 
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Table 4.2 Univariate linear regression between participant characteristics and subclinical CVD measures. 
 
Characteristic Mean IMT (n = 229) Mean AD (n = 231) Mean LD (n = 232) 
Age (years) 0.007 (0.006, 0.008) ¥ 0.015 (0.010, 0.021) ¥ 0.001 (-0.04, 0.006) 
Female -0.039 (-0.082, 0.003) -0.328 (-0.526, -0.130) † -0.260 (-0.427, -0.092) † 
Education (≥ secondary) -0.107 (-0.146, -0.069) ¥ -0.436 (-0.621, -0.250) ¥ -0.214 (-0.376, -0.053) † 
Alcohol (> 1 drink/week) 0.001 (-0.041, 0.043) -0.005 (-0.206, 0.196) 0.003 (-0.167, 0.172) 
Smoke (100+ cigs) 0.056 (-0.016, 0.129) 0.508 (0.168, 0.848) † 0.389 (0.098, 0.680) † 
Walking (> 30 mins/wk) -0.015 (-0.064, 0.033) -0.015 (-0.247, 0.216)  0.022 (-0.169, 0.214) 
Married 0.094 (0.055, 0.133) ¥ 0.280 (0.089, 0.470) † 0.077 (-0.087, 0.241) 
SBP (mmHg) 0.003 (0.003, 0.004) ¥ 0.011 (0.007, 0.015) ¥ 0.005 (0.001, 0.008) † 
DBP (mmHg) 0.005 (0.004, 0.007) ¥ 0.015 (0.008, 0.022) ¥ 0.005 (-0.002, 0.011) 
HDL (mg/dL) -0.001 (-0.002, 0.001) -0.006 (-0.014, 0.001) -0.005 (-0.011, 0.002) 
LDL (mg/dL) 0.001 (0.001, 0.002) ¥ 0.003 (0.0003, 0.005) † 0.0003 (-0.002, 0.002) 
Log Triglycerides (mg/dL) 0.124 (0.075, 0.174) ¥ 0.212 (-0.032, 0.456) -0.024 (-0.233, 0.186) 
Log Glucose (mg/dL) 0.205 (0.122, 0.289) ¥  0.746 (0.344, 1.149) † 0.324 (-0.031, 0.679) 
Log CRP (mg/dL) 0.013 (-0.003, 0.029) 0.064 (-0.012, 0.141) 0.037 (-0.029, 0.103) 
Height (cm) -0.002 (-0.005, 0.0003) 0.015 (0.003, 0.027) * 0.019 (0.009, 0.029) † 
Waist (cm) 0.003 (0.002, 0.005) ¥ 0.017 (0.011, 0.023) ¥ 0.011 (0.006, 0.016) ¥ 
 
Values presented as β coefficient estimates (95% CI) 
¥ p-value < 0.0001, † p-value < 0.01, * p-value <0.05  
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Table 4.3 Multivariable linear regression between participant characteristics and subclinical CVD measures. 
 
Covariate Mean IMT (n=216) Mean AD (n = 218) Mean LD (n = 219) 
Age (years) 0.006 (0.005, 0.007) ¥ 0.008 (0.001, 0.016) * -0.005 (-0.011, 0.002) 
Female -0.040 (-0.078, -0.002) * -0.091 (-0.326, 0.143) -0.033 -0.247, 0.181) 
SBP (mmHg) 0.001 (0.0002, 0.002) * 0.005 (0.001, 0.010) * 0.004 (-0.0005, 0.008) 
Waist (cm) 0.001 (0.0004, 0002) † 0.012 (0.007, 0.018) ¥ 0.010 (0.005, 0.015) † 
Height (cm) -0.0003 (-0.003, 0.002) 0.018 (0.004, 0.032) * 0.017 (0.004, 0.029) * 
Education (≥ secondary) 0.021 (-0.012, 0.054) -0.168 (-0.372, 0.036) -0.200 (-0.387, -0.014) * 
 
Values presented as β coefficient estimates (95% CI) 
¥ p-value < 0.0001, † p-value < 0.01, * p-value <0.05  
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Table 4.4 Single multivariable linear regression models between participant characteristics 
and subclinical CVD measures illustrating the effect of education for females and males 
 
Covariate Mean IMT (n = 216) p -value  (interaction) 
Age 0.006 (0.005, 0.007) ¥  
Female -0.042 (-0.086, 0.001)   
SBP 0.001 (0.0002, 0.0002) †  
Height  -0.0003 (-0.003, 0.002)   
Waist 0.001 (0.0004, 0.002) †  
Education for Females 0.024 (-0.015, 0.062)  0.82 Education for Males 0.016 (-0.037, 0.069)  
 
Covariate Mean AD (n = 218) p -value  (interaction) 
Age 0.009 (0.002, 0.017) *  
Female 0.033 (-0.234, 0.299)  
SBP 0.004 (-0.00004, 0.009)  
Height  0.016 (0.002, 0.030) *  
Waist 0.012 (0.006, 0.017) ¥  
Education for Females -0.283 (-0.519, -0.047) * 0.061 Education for Males 0.074 (-0.251, 0.398) 
 
Covariate Mean LD (n = 219) p -value  (interaction) 
Age -0.004 (-0.011, 0.003)  
Female 0.106 (-0.136, 0.349)  
SBP  0.003 (-0.001, 0.007)  
Height  0.015 (0.003, 0.028) *  
Waist 0.010 (0.004, 0.015) †  
Education for Females -0.330 (-0.544, -0.115) † 0.021 Education for Males 0.072 (-0.223, 0.367) 
 
Values presented as β coefficient estimates (95% CI) 
Unadjusted interaction between gender and education for IMT (p-value = 0.83) 
Unadjusted interaction between gender and education for AD (p-value = 0.0066) 
Unadjusted interaction between gender and education for LD (p-value = 0.0014) 
¥ p-value < 0.0001, † p-value < 0.01, * p-value <0.05  
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Figure 4.1 Adjusted means for average adventitial and lumen diameters by education level for males and females 
Mean diameters adjusted for age, SBP, height and waist circumference. 
 
 
 
 
 
 
p = 0.19 
p = 0.0010 
p = 0.0051 
p = 0.18 
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Figure 4.2 Age adjusted means for cardiovascular risk factors by education level for males and females. 
Adjusted for age. 
p = 0.048 
p = 0.79 p = 0.45 
p = 0.0025 
p = 0.36 p = 0.61 p = 0.0048 
p = 0.66 
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5.1 ABSTRACT 
 
Background:  Autonomic nervous system (ANS) activity is known to modulate inflammation.  
Tonic and reactivity measures of sympathetic and parasympathetic activity, determined by 
heart rate variability (HRV), and C-reactive protein (CRP) have been associated cross-
sectionally and prospectively with subclinical and incident cardiovascular disease (CVD).  
This analysis aimed to determine which CVD risk factors predicted HRV, CRP and aortic 
pulse wave velocity (PWV), a validated measure of arterial stiffening. Also determined was 
how HRV and CRP together predicted aortic PWV.  Methods: Indicators of tonic HRV and 
HRV reactivity, in response to standard autonomic challenges, were obtained with 
continuous heart rate and respiratory rate recordings in 240 moderately overweight and 
obese young adult men and women from the study to Slow Adverse Vascular Effects 
(SAVE). Results: Tonic sympathetic cardiac activity was positively associated with aortic 
PWV, while parasympathetic reactivity to a deep breathing challenge was inversely 
associated with aortic PWV, even after adjustment for CVD risk factors (β = 36.3, p-value = 
0.029 and β = -35.1, p-value = 0.0085, respectively).  Cardiac parasympathetic activity 
during deep breathing was inversely associated with CRP (β = -0.208, p-value = 0.0059), 
and CRP was positively associated with aortic PWV (β = 19.9, p-value = 0.057) in a 
multivariable model, but was attenuated after adjusting for parasympathetic reactivity during 
deep breathing (β = 14.5, p-value = 0.17).  Conclusions: In overweight and obese young 
adults, tonic cardiac sympathetic activity and parasympathetic reactivity were independent 
predictors of arterial stiffening.  The significant findings observed for indicators of HRV, but 
not CRP, may be explained by autonomic anti-inflammatory mechanisms linking HRV and 
CRP. 
 73 
5.2 INTRODUCTION 
 
Heart rate variability (HRV) and the inflammatory biomediator, C-reactive protein (CRP), are 
known predictors of future cardiovascular events 1-8.  Measures of HRV provide an indirect 
index of autonomic nervous system (ANS) activity, which is instrumental for regulating 
peripheral levels of inflammatory biomediators 9.  Moreover, emerging evidence has linked 
dysregulated activity in the sympathetic and parasympathetic divisions of the ANS with 
increased risk for inflammatory diseases, including coronary atherosclerosis 2.  Aortic pulse 
wave velocity (PWV) is a validated measure of subclinical cardiovascular disease (CVD), 
and is a known predictor of myocardial infarction, stroke and CVD mortality 10-12.  The 
associations between HRV and PWV and between CRP and PWV have been reported, yet 
prior findings are conflicting and the two autonomic and inflammatory predictors of PWV, 
HRV and CRP, have not been evaluated together. 
 More precisely, few studies have assessed the association between HRV and PWV.  
In young Japanese adult men, an HRV indicator of tonic sympathetic activity was positively 
associated with brachial ankle PWV; however, no association was observed for tonic 
parasympathetic activity 13.  Further, HRV indicators and carotid femoral PWV were not 
associated in UK adult men 14.  Additionally, in a case-control study of East Asian men and 
women, no significant HRV-brachial ankle PWV associations were found in the control 
group 15.  Critically, no study evaluated the relative predictive roles of tonic sympathetic and 
parasympathetic HRV indicator variables in the same models of PWV.    
CRP is a marker of general inflammation and a robust predictor of incident CVD; 
however, findings regarding whether CRP is an independent predictor of PWV are mixed 6.  
In diverse cohorts of adult men and women, positive associations between CRP and PWV 
have been reported, with adjustment for traditional CVD risk factors 16-23.  Other studies 
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have also observed an attenuation of association estimates after adjustment for similar 
factors 24-26.  In one report, a significant CRP-brachial ankle PWV association was observed 
only in men 27. 
An inverse association between indicators of HRV and CRP has been reported in 
several studies, suggesting decreased HRV is associated with peripheral inflammation.  In 
the CARDIA study, CRP was inversely associated in multivariable models with both low- 
and high-frequency HRV measures, which are thought to reflect sympathetic (LF-HRV) and 
parasympathetic (HF-HRV) levels of cardiac control, respectively 28.  HRV indicators of tonic 
sympathetic activity have also been inversely associated with CRP in several other 
populations of men and women 29-31.  Cross-sectionally, HF-HRV indicators of tonic 
parasympathetic activity have also been inversely associated with CRP; however, recent 
longitudinal findings suggest a possible direct relationship between HF-HRV  CRP 32, 33.  
In a large population of men and women from Germany, a significant inverse association 
between tonic parasympathetic activity and CRP was documented after adjustment for tonic 
sympathetic activity 34.  Only one of the mentioned studies used a measure of HRV 
reactivity, as opposed to tonic activity, in response to a relaxation exercise, and no study 
has evaluated HRV reactivity to standard autonomic challenges 32.   
Increased autonomically-mediated cardiovascular reactivity (blood pressure and 
heart rate changes) in response to stressors have shown to predict subclinical and incident 
CVD 35, 36.  Furthermore, cardiac parasympathetic reactivity in response to an impromptu 
speech challenge, was independently predicative of coronary calcification in the Healthy 
Women’s Study 37.  Hence, measures of HRV reactivity in addition to tonic HRV may 
provide additional insight into the mechanisms by which the ANS regulates inflammation 
and inflammatory diseases.   
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The classic method for analyzing HRV is limited because the LF-HRV component is 
affected by both sympathetic and parasympathetic outflow, whereas the HF-HRV 
component is a closer marker of parasympathetic (vagal) outflow 38.  Because respiratory 
rate strongly determines parasympathetic cardiac outflow, it can be used to improve the 
validity of the LF-HRV component as an index of autonomic activity 39.  Specifically, deriving 
HF-HRV spectral power estimates from bandwidths centered at respiratory spectral peak 
may allow for a better partitioning of sympathetic and parasympathetic contributions to LF- 
and HF-HRV estimates 40.  Mixed reports in previous literature regarding HRV indicators 
may be due to the limitation of the LF-HRV as an indicator of sympathetic outflow. 
Three studies to date have evaluated the relationship between HRV and PWV in 
healthy adults, and only one of these included females.  Furthermore, no study has 
assessed HRV-PWV associations in conjunction with CRP.  The research supporting the 
association between HRV reactivity and aortic calcification warrants further investigation 
into other markers of subclinical atherosclerosis.  Using a measure of sympathetic and 
parasympathetic outflow that adjusts for respiratory rate may improve the predictability of 
the LF-HRV estimates.  Using both measures of sympathetic and parasympathetic outflow 
simultaneously and including HRV reactivity to a Valsalva (index of sympathetic reactivity) 
and deep breathing (index of parasympathetic reactivity) challenge may provide further 
evidence into how indicators of HRV relate to early atherosclerotic changes.  
Accordingly, the purpose of this report was to determine which CVD risk factors 
predicted HRV, CRP and aortic PWV in a population of moderately overweight and obese 
young adult men and women from the study to Slow Adverse Vascular Effects (SAVE).  
Additional aims were to examine the predictive effects of HRV and CRP together on aortic 
PWV, and finally, how reactivity measures of HRV to standard autonomic challenges, in 
addition to tonic measures of HRV, relate to aortic PWV.  
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5.3 METHODS 
 
5.3.1 Study Population 
 
The study to Slow Adverse Vascular Effects (SAVE) is a randomized clinical trial designed 
to test the impact of a dietary and an activity intervention on arterial stiffening.  A total of 349 
overweight to obese (BMI 25 - 39.9 kg/m2) men and women from Allegheny County, 
Pennsylvania, between the ages of 20 and 45 years, were randomized.  To be eligible for 
the SAVE study participants had to have a blood pressure < 140/90 mmHg and a fasting 
glucose < 126 mg/dL.  Potential participants were ineligible if they had a known history of 
weight loss surgery, CVD, inflammatory disease or a condition where salt restriction would 
be harmful.  Anyone who was pregnant/nursing, on lipid lowering medication or on 
vasoactive medication was ineligible for the study.  The University of Pittsburgh institutional 
review board approved research protocols for the SAVE study.  All participants provided 
written informed consent prior to enrollment.   
The goal of the intervention was a 10% weight reduction and an increase in activity 
of 150 - 200 minutes per week.  In addition to the combined effects of weight loss and 
increased activity, the effect of a 50% sodium reduction on arterial stiffening was observed.  
This study has two treatment arms: weight loss, increased physical activity and normal sodium 
intake versus weight loss, increased physical activity and 50% reduction in sodium intake.  The 
following measures of vascular health were assessed at baseline, 6, 12 and 24 months: 
aortic and peripheral pulse wave velocity (PWV), carotid intima media thickness (IMT), 
carotid adventitial diameter (AD) and endothelial function.  The primary outcome of the 
SAVE study was aortic PWV following 6 months of intervention. 
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An ancillary study to the parent study, SAVE, assessed heart rate variability (HRV) 
at baseline and at the 6 month follow up visit.  Of the 349 randomized participants, 300 
were available for this baseline analysis.  A final sample size of 240 participants was used 
because 60 participants had missing HRV and aortic PWV data.  Participants with missing 
data had significantly higher leptin levels and higher household income compared to those 
included in this analysis.  All other variables were equally distributed. 
 
5.3.2 Heart Rate Variability 
 
HRV was measured using an ANSAR monitor (ANX-3.0, ANSAR Group Inc, Philadelphia, 
Pennsylvania), which provides for continuous and noninvasive measurements of 
electrocardiogram signals (for HRV assessment) and bioimpedance plethysmography 
signals (for respiratory rate variability assessment; RRV), respectively.  Testing began with 
attachment of electrocardiogram electrodes in a modified Lead-II configuration to the 
participant’s chest, along with a blood pressure cuff to the left arm.  Participants were asked 
to sit with their feet flat on the floor and refrain from sudden movements or talking.  Resting 
measures at a normal breathing rate were taken for 5 minutes followed by deep breathing 
(6 breaths per minute) for 1 minute.  Participants returned to their resting rate for 1 minute, 
performed Valsalva challenge for 1.5 minutes and returned to resting again for 2 minutes.  
To finish, participants remained in a standing position for 5 minutes.   
A spectral analysis of the HRV and RRV was generated using ANSAR software.  
The low-frequency area (LFa) was centered on the HRV spectrum from 0.04 - 0.10 Hz, 
which is taken to reflect sympathetic cardiac activity.  From the spectral analysis of the 
RRV, the frequency of the peak mode was defined as the fundamental respiratory 
frequency (FRF).  A 0.12 Hz wide window from the HRV spectrum was centered at the FRF 
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and was used to generate the respiratory frequency area (RFa), which is taken to reflect 
parasympathetic cardiac activity 39-42.  During low FRF, the RFa shifts into the low-frequency 
bandwidth. The area under the spectral curve centered on the FRF is computed as RFa.  
The remaining area under the spectral curve in the low-frequency bandwidth is computed 
as LFa.   
Four measures of HRV were identified for subsequent analyses:  (1) LFa and (2) 
RFa during the initial 5 minute resting period (corresponding to tonic sympathetic and 
parasympathetic activity levels, respectively) and (3) LFa and (4) RFa during the Valsalva 
and deep breathing challenge, respectively (corresponding to sympathetic reactivity to the 
Valsalva maneuver, and to parasympathetic reactivity to deep breathing, respectively).  
Reproducibility analyses between 3 technologists were conducted on 30 participants (10 for 
each pair).  Between technologist reproducibility intraclass correlation coefficients (ICC) 
ranged from 0.61 to 0.93 for the four HRV measures.  
 
5.3.3 Pulse Wave Velocity 
 
Aortic PWV was measured using an automatic waveform analyzer (Colin, Cardio Vascular 
Profiling System, VP1000, Omron Healthcare Co, Komaki, Japan). Methodology has been 
previously published 43.  Once pulse waves, electrocardiogram and phonocardiogram were 
stable, pulse waves were captured for 10 seconds.  A second 10 second recording was 
obtained and the two runs were averaged.  The technologist measured the distance from 
the suprasternal notch to the umbilicus and from the umbilicus to the femoral artery (∆Lhf).  
The Colin machine estimated the time for the blood to travel from the heart to the femoral 
artery by summing the interval between the second heart sound and the carotid dicrotic 
notch (∆Thc) plus the interval between the foot of the carotid pulse to the femoral pulse 
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(∆Tcf).  The heart femoral PWV, measure of aortic PWV, was calculated as (∆Lhf) / (∆Thc + 
∆Tcf).  Within-technologist ICC was 0.88 for heart femoral PWV. 
 
5.3.4 Covariates 
 
Demographic factors such as age, martial status, alcohol use and smoking were obtained 
through questionnaires at the baseline visit.  Participants were asked their highest level of 
education completed.  Race and ethnicity were self-defined.  Blood pressure was collected 
by a standard sphygmomanometer in the right arm of participants after a 5 minute rest 
period.  A total of three pressures were collected and the last two were averaged. 
Participants were weighted in light clothing and without shoes.  Waist circumference was 
collected to the nearest 0.1 cm at the narrowest portion of the torso in each participant.  
Fasting blood samples were collected and analyzed at Heinz Laboratory (University of 
Pittsburgh, Pittsburgh, Pennsylvania). Serum glucose was quantitatively determined by an 
enzymic reaction as previously described 44.  HDL-c (mg/dL) was determined using the 
enzymatic method of Allain et al. and LDL-c (mg/dL) was estimated with the Friedewald 
equation 45, 46.  CRP was quantified with an enzyme-linked immunoassay (Alpha Diagnostic 
International, Inc).  Finally, leptin, adiponectin and ghrelin were determined using 
radioimmunoassay kits (Linco Research, Inc).  
 
5.3.5 Statistical Analysis 
 
Baseline visit data from the SAVE study was used in this report.  Continuous variable 
distributions were assessed for normality.  Natural log transformations were performed to 
approximate a normal distribution when needed.  Insulin, CRP, ghrelin, and the four HRV 
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measures were naturally log transformed for regression analyses; however, medians (IQR) 
are presented in Table 1.  All other continuous variables were analyzed without 
transformation.  Categorical variables were collapsed into the following cutoffs to maintain 
adequate sample size in each category: education was dichotomized into ≤ secondary 
education versus tertiary education, household income was divided into ≤ $75,000 versus > 
$75,000, marital status was categorized into married versus divorced/separated, widowed 
or single, smoking status into ever smokers versus never smokers and alcohol into at least 
one drink per month versus no alcohol.  Lastly, black race was compared to non-black race 
to assess the impact of black race on HRV, CRP and aortic PWV.   
Univariate linear regression was performed with CVD risk factors as predictors of 
HRV, CRP and aortic PWV.  LFa during Valsalva and RFa during deep breathing were 
evaluated in bivariate and multivariable regression models adjusted for LFa at rest and RFa 
at rest, respectively.  Model variance inflation factors ≤ 2.0 were verified to reduce the risk 
of multicollinearity.  Stepwise linear regression was utilized to determine which CVD risk 
factors remained independent predictors for HRV, CRP and aortic PWV.  Weight was 
chosen in multivariable models because it explained more of the variation compared to BMI. 
Models repeated using BMI showed similar results to those including waist circumference.  
Statistical analyses were completed in SAS 9.1 and two sided p-values ≤ 0.05 were 
considered statically significant.       
 
5.4 RESULTS 
 
Complete characteristics for the 240 SAVE participants used in this analysis are reported in 
Table 1.  The average age was 38 years, with fifty-six male participants (23%) and 38 (16%) 
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defining themselves as black.  Thirty-six percent had ever smoked and 50% drank one or 
more alcoholic beverages per month.  The average BMI was 32.8 kg/m2.  Participants were 
normotensive (114/73 mmHg) and normoglycemic (97 mg/dL).  The median CRP was 2.4 
mg/dL and ranged from 1.3 to 5.5 mg/dL.  Average mean aortic PWV was 818 cm/sec.  
In univariate linear regression models (data available on request), age was inversely 
associated with LFa and RFa at rest, and continued to be an independent predictor in 
multivariable models (Table 2).   Weight was directly related to LFa at rest and LFa during 
Valsalva and inversely to RFa at rest and RFa during deep breathing; however, after 
adjusting for age and male gender, weight was not independently related to LFa at rest.  
Using stepwise regression, LFa at rest and RFa at rest were independent predictors of LFa 
during Valsalva and RFa during deep breathing, respectively.  CRP was only a significant 
predictor of RFa during deep breathing.   
Independent predictors of CRP included adiponectin, leptin and RFa during deep 
breathing (Table 3).  RFa during deep breathing was significant unadjusted and adjusted for 
RFa at rest.  
LFa at rest, RFa at rest and LFa during Valsalva (unadjusted and adjusted for RFa 
at rest) were not associated with aortic PWV in univariate and bivariate analyses, whereas 
RFa during deep breathing, unadjusted and adjusted for RFa at rest, significantly predicted 
aortic PWV (data available on request).  LFa at rest and RFa during deep breathing 
(unadjusted and adjusted for RFa at rest) were independent predictors of aortic PWV in 
multivariable regression (Table 4).  LFa at rest and RFa during deep breathing (adjusted for 
RFa at rest) remained significant predictors after adjustment for heart rate, LFa during 
Valsalva and remaining CVD risk factors: weight, LDL-c, insulin, adiponectin, leptin, ghrelin, 
alcohol, male gender, smoking, education, marital status and household income (data 
available on request).  CRP was not a significant predictor of aortic PWV in univariate 
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analysis (β = 14.4 p-value = 0.21).  After adjustment for age, SBP, height, HDL-c, black 
race, LFa at rest and RFa at rest, CRP was borderline directly associated with aortic PWV 
(β = 19.9, p-value = 0.057), but was attenuated after adjusting for RFa during deep 
breathing (β = 14.5, p-value = 0.17). 
 
5.5 DISCUSSION 
 
Indicators of HRV independently predicted aortic PWV in a population of overweight and 
obese young adults.  Tonic sympathetic cardiac activity, as reflected by resting LFa in this 
study, was positively associated with aortic PWV, while parasympathetic reactivity to deep 
breathing, as reflected by RFa, was inversely associated with aortic PWV, even after 
adjustment for CVD risk factors.  The significant association with tonic sympathetic cardiac 
activity accords with findings from Nakao M et al., who observed a positive association with 
the low-frequency/high-frequency ratio and brachial ankle PWV in a multivariable model 13.   
No association was observed for tonic parasympathetic cardiac activity in the Nakao 
population and in SAVE participants.  However, the SAVE study included a measure of 
parasympathetic reactivity during deep breathing, which was significantly associated with 
aortic PWV, but tonic and reactivity measures of HRV cannot be compared directly.  This is 
an important finding in that parasympathetic cardiac reactivity, as opposed to tonic 
parasympathetic activity, may be a better predictor of subclinical CVD.  Moreover, 
parasympathetic reactivity measures may reflect a homeostatic ability to adapt to 
environmental challenges and stressors and potentially compensate for hypersympathetic 
outflow 47. 
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Additionally, the Nakao population of men, were 24 to 39 years in age, which is 
similar to the SAVE study participants.  On the other hand, no females were included, the 
mean BMI was much lower compared to SAVE participants and arterial stiffening was 
assessed using brachial ankle PWV, a measure of peripheral stiffening, whereas the SAVE 
study used aortic PWV, a measure of central stiffening.  Despite these differences, similar 
results were found for HRV measures of sympathetic activity.  This is in contrast to the two 
additional studies reporting negative results for the association between HRV and PWV.  
The first, used carotid femoral PWV, a measure of central stiffening, among a population of 
UK men; however, the age range, 40 to 60 years, exceeded that of the SAVE study 14.  The 
second found no significant correlation with brachial ankle PWV, again a measure of 
peripheral stiffening, among the normal controls in a case-control study.  A potential reason 
for the lack of association may be the measure of sympathetic cardiac activity used (QT 
interval variability), which has been shown to only moderately correlated with low-frequency 
HRV, which is not a pure measure of sympathetic outflow 15, 48.  Also, a very small sample 
size (n=23) was used, and only 4 females were included.  The lack of females in all these 
studies may partially account for the differences in reported findings 49.  Besides the study 
design dissimilarities in HRV and PWV measures, the multivariable models did not 
incorporate separate measures of sympathetic and parasympathetic cardiac activity 
simultaneously.   
The two branches of the ANS regulate target organ activity concurrently, and 
therefore evaluating activity in one branch without the other may yield an incomplete picture 
of ANS control.  The health status of the ANS is likely to reflect an overall autonomic 
regulatory capacity and flexibility to adapt to change; however, understanding of these 
processes as they relates to cardiovascular health is evolving 50.  Both measures of 
sympathetic and parasympathetic cardiac control were predictive of prior myocardial 
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infarction in separate models; however, an overall measure of HRV regulation (summation 
of sympathetic and parasympathetic activation) was inversely related to prior myocardial 
infarction even after adjusting for sympathetic and parasympathetic control.  This suggests 
that not only does each branch of the ANS affect health outcomes, but also the overall 
ability of the ANS to adapt to change adds valuable information regarding disease 
processes.  Examining both tonic sympathetic and parasympathetic activity, in addition to 
reactivity, in the SAVE study demonstrated that both branches predict arterial stiffening 
adjusting for each other.  Furthermore, tonic sympathetic activity only became an 
independent predictor of aortic PWV once differences in parasympathetic reactivity were 
accounted for, suggesting the relationship between the two branches may offer additional 
insight into mechanisms of disease. 
Another significant finding in this report was the association between HRV and CRP.  
Cardiac parasympathetic activity during deep breathing, as reflected by RFa, was inversely 
associated with CRP, however tonic parasympathetic at rest was not a significant predictor.  
These findings suggest HRV reactivity may also be a better predictor of inflammation than 
tonic HRV.  On the other hand, Nolan et al, Thayer et al. and Singh et al. observed an 
inverse association between tonic parasympathetic cardiac activity measures and CRP 32, 33, 
34.  Differences in the health status of the three populations compared to SAVE participants 
may account for these conflicting findings.  SAVE participants were relatively healthy; no 
history of hypertension, diabetes or CVD, whereas Thayer and Nolan included participants 
with known CVD and all three studies included participants who were on anti-hypertensive 
and anti-diabetic medications. Nolan used a measure of parasympathetic reactivity during a 
self guided relaxation technique, however, the model depicted tonic parasympathetic 
activity and CRP predicting parasympathetic reactivity, whereas the SAVE study evaluated 
how reactivity adjusted for tonic basal activity predicted CRP.  Thayer additionally adjusted 
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tonic sympathetic activity for urinary norepinephrine (NE) in a multivariable model, however, 
NE was not a significant independent predictor of CRP, which is similar to the SAVE study 
in that tonic sympathetic activity at rest was not a significant predictor.  Conversely, tonic 
sympathetic activity has been shown to be inversely associated with CRP among several 
other populations of men and women 29-31.  These studies, however, included older adults 
compared to the SAVE study, and used measures of sympathetic activity (LF-HRV and 
SDNN) that may actually reflect both tonic sympathetic and parasympathetic activity.  These 
conflicting results suggest that the association between measures of HRV and CRP is 
complex and factors such as age, health status of the study population and methodology 
used to capture HRV may affect the findings.  Nevertheless, overall, the literature and this 
report indicate a connection between HRV and CRP. 
CRP was positively associated with aortic PWV, but was attenuated once 
parasympathetic reactivity during deep breathing was added to the model.  This is 
consistent with the studies showing a non-significant relationship between CRP and aortic 
PWV once adjusted for CVD risk factors, however, none of these studies adjusted for HRV 
24-26.  Given the significant association between parasympathetic reactivity during deep 
breathing and CRP, it is plausible that the variation in aortic PWV explained by CRP is 
accounted for by parasympathetic reactivity.  There is evidence suggesting a causal 
pathway linking HRV  CRP  CVD via cholinergic anti-inflammatory mechanisms 51.  
Higher cardiac parasympathetic activity during paced respiration, was shown to be 
associated with lower cytokine production (IL6 and TNFα) in adult men and women from the 
Adult Health and Behavior project, supporting the relationship between parasympathetic 
activity and inflammatory competence 52.  Additionally, the direct association observed in 
longitudinal analysis of HRV and CRP also support the cholinergic anti-inflammatory 
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mechanisms; those with higher CRP had higher tonic parasympathetic activity a year later 
33.  
This analysis is unique because tonic and reactivity HRV measures of sympathetic 
and parasympathetic function were assessed and considered together with CRP in models 
predicting an indicator of subclinical CVD, aortic PWV.  Tonic levels and reactivity 
differences between individuals likely convey different information regarding the status of 
the ANS.  It is plausible that changes in reactivity due to age, weight or other CVD risk 
factors may precede changes to tonic levels or visa versa.  The lack of association with 
LFa, reflecting sympathetic cardiac activity, during the Valsalva challenge may be due 
insufficient power given the large standard deviation of the HRV measures.  Further 
research into the role of tonic versus reactivity measures and how they relate to subclinical 
CVD need to be assessed in longitudinal studies and larger samples sizes.  Because HRV, 
CRP and aortic PWV are measured at the same time point, the mechanisms linking HRV 
and aortic PWV via CRP should be interpreted cautiously.  It is plausible that changes in 
blood flow return to the heart due to arterial stiffness could lead to changes in cardiac output 
and subsequently changes to autonomic outflow; however, adjustment for heart rate did not 
attenuate the associations between HRV and aortic PWV in this report (data available on 
request).  Unfortunately, the relatively small sample size of black race and males prohibits 
the comparison of differences between groups.  Further research needs to evaluate racial 
and gender differences in the observed associations.  Lastly, a measure of physical activity 
at baseline was not available for this analysis, which is known to affect HRV; therefore 
residual confounding could account for some of the variability observed 53. 
Analysis of the 6 month follow up visit data will be evaluated once it becomes 
available.  Findings from this report provide empirical basis to test whether dietary changes 
impact subclinical disease via autonomic-inflammatory pathways. The effects of weight 
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reduction and increased physical activity on HRV, CRP and aortic PWV will be assessed.  
In addition, the effect of sodium reduction on HRV, CRP and aortic PWV will be determined.  
Evaluation of the changes in HRV and CRP and how they affect the observed associations 
seen in this report will be the primary focus.  
In conclusion a measure of tonic cardiac sympathetic activity and parasympathetic 
reactivity were independent predictors of arterial stiffening, as measured by aortic PWV.  
CRP is a known marker of general inflammation and a predictor of clinical and subclinical 
CVD.  However, this analysis suggests the variability in aortic PWV explained by CRP may 
be explained, in part, by autonomic anti-inflammatory mechanisms linking HRV and CRP.  
This report is significant because therapeutic approaches targeted at autonomic activity 
may be more successful at reducing CVD compared to those aimed at CRP, which may 
only be part of the causal pathway. 
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5.6 TABLES FOR CHAPTER FIVE 
 
Table 5.1 Participant characteristics  
 
Characteristic Total (n=240) 
Age (years) 38.1 (6.0) 
Males (%, n) 23.3 (56) 
Blacks (%, n) 15.8 (38) 
Tertiary Education (%, n) 69.2 (166) 
Income <$75,000 (%, n) 57.0 (134) 
Married (%, n) 60.0 (144) 
Ever smoke (%, n) 35.8 (86) 
Alcohol > once/month (%, n) 50.0 (120) 
BMI (kg/m2) 32.8 (3.8) 
Waist Circumference (cm) 100.2 (11.2) 
Weight (kg) 92.0 (15.1) 
Height (cm) 167.2 (8.5) 
SBP (mmHg) 113.5 (10.7) 
DBP (mmHg) 73.1 (8.5) 
LDL (mg/dL) 122.5 (32.8) 
HDL (mg/dL) 52.1 (13.0) 
Glucose (mg/dL) 97.4 (8.1) 
Insulin (µU/mL) * 12.4 (9.4, 18.2) 
CRP (mg/dL) * 2.4 (1.3, 5.5) 
Leptin (mg/dL) 24.5 (12.3) 
Ghrelin (mg/dL) * 657 (539, 879) 
Adiponectin (mg/dL) 11.9 (5.7) 
Mean Aortic PWV (cm/sec) 818 (188.9) 
LFa at Rest (bpm2) * 1.8 (1.1, 3.5) 
LFa during Valsalva (bpm2) * 53.2 (29.5, 92.1) 
RFa at Rest (bpm2) * 1.8 (1.0, 3.2) 
RFa during Deep Breathing (bpm2) * 25.7 (13.5, 47.4) 
 
Values presented as means (SD) or % (n) where indicated.     
* Non-normal distribution; values are presented as medians (IQR) 
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Table 5.2 Independent predictors of heart rate variability measures in multivariable linear 
regression models 
 
HRV Measure 
     Predictors Beta Estimate p-Value 
95% Confidence 
Interval 
LFa at Rest * 
     Age  -0.035 <0.0001 -0.052, -0.019 
     Male gender 0.268 0.025 0.034, 0.502 
LFa during Valsalva * 
    Weight 0.009 0.015 0.002, 0.016 
    Adiponectin -0.023 0.015 -0.041, -0.005 
    LFa at Rest * 0.237 0.0003 0.111, 0.362 
RFa at Rest * 
    Age -0.031 0.0016 -0.050, -0.012 
    Weight -0.011 0.0041 -0.019, -0.004 
RFa during Deep Breathing * 
    Weight -0.007 0.042 -0.014, -0.0003 
    CRP * -0.149 0.0028 -0.247, -0.052 
    RFa at Rest * 0.353 <0.0001 0.237, 0.469 
 
* Non-normal distribution; measure natural log transformed 
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Table 5.3 Independent predictors of natural logarithm of C-reactive protein in a multivariable 
linear regression model 
 
Predictors Beta Estimate p-Value 95% Confidence Interval 
Adiponectin -0.044 <0.0001 -0.066, -0.023 
Leptin 0.033 <0.0001 0.023, 0.043 
RFa during Deep breathing * -0.208 0.0059 -0.355, -0.060 
RFa at Rest * 0.033 0.66 -0.114, 0.180 
 
* Non-normal distribution; measure natural log transformed 
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Table 5.4 Independent predictors of mean aortic pulse wave velocity in a multivariable linear 
regression model 
 
Variable Beta Estimate p-Value 95% Confidence Interval 
Age 10.9 <0.0001 7.1, 14.6 
SBP 2.0 0.062 -0.1, 4.1 
Height 3.1 0.028 0.3, 5.8 
HDL -2.2 0.015 -3.9, -0.4 
Black race 77.4 0.014 15.8, 139.0 
LFa at Rest * 36.3 0.029 3.7, 68.9 
RFa during Deep Breathing * -35.1 0.0085 -61.1, -9.0 
RFa at Rest * -1.8 0.91 -31.5, 28.0 
 
* Non-normal distribution; measure natural log transformed 
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6.0 GENERAL DISCUSSION 
 
 
6.1 SUMMARY OF FINDINGS 
 
This dissertation aimed to evaluate novel risk factor associations for subclinical CVD in 
three distinct populations.  A summary of the findings for chapters 3, 4 and 5 are presented 
below.  
 In chapter 3, the protective effect of HDL-c for subclinical CVD appeared to diminish 
in late perimenopausal and postmenopausal (LP/Post) women compared to premenopausal 
and early perimenopausal (Pre/EP) women.  Specifically, HDL-c was protective against 
aortic calcification, carotid plaque and intima medial thickness among the Pre/EP women, 
but directly associated with subclinical CVD among the LP/Post women.  Furthermore, in a 
subcohort of women, the concentration of small HDL-c particles was higher in LP/Post 
compared to Pre/EP women.  These findings suggest that lipid profile changes with the 
menopausal transition may in part explain the increased risk of CVD seen after menopause. 
 In chapter 4, the protective effect of education for adventitial and lumen diameter 
was evident only among females from an Afro-Caribbean population.  In addition, females 
with higher education had lower SBP than those with lower education, and higher educated 
males had higher LDL-c and lower HDL-c compared to lower educated males.  These 
educational differences in CVD risk factors for males and females provide potential 
mechanisms for the education-subclinical CVD relationship observed on the island of 
Tobago. 
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In chapter 5, measures of heart rate variability (HRV) predicted subclinical 
atherosclerosis in a population of overweight and obese young adults.  Specifically, tonic 
cardiac sympathetic activity and parasympathetic reactivity were independent predictors of 
aortic pulse wave velocity.  The effect of C-reactive protein (CRP) on arterial stiffening is 
potentially explained by the autonomic anti-inflammatory mechanisms linking HRV and 
CRP.  Therapeutic approaches targeted at autonomic activity may aid in the reduction of 
CVD. 
 
6.2 PUBLIC HEALTH SIGNIFICANCE 
 
Myocardial infarctions and strokes are the leading causes of death worldwide.  Both men 
and women are at increased risk for CVD due to rising rates of obesity, smoking, diabetes, 
hypertension and hyperlipidemia.  Understanding how these risk factors impact early 
atherosclerosis is imperative to the prevention and early detection of CVD.  Findings from 
this dissertation emphasize the need to potentially change the way in which CVD risk is 
assessed in various populations.  Specifically, changes in lipid profiles associated with the 
menopausal transition suggest the need to evaluate HDL-c and HDL particle size as women 
transition through menopause.   High levels of HDL-c may not confer the same protection 
for premenopausal and postmenopausal women.  Furthermore, the protective effects of 
education on CVD risk factors and early atherosclerosis differ for Afro-Caribbean males and 
females.  Opportunities to advise this population on healthy lifestyle choices in a clinical 
setting may be missed if assumptions are made that males with higher education have 
lower CVD risk.  Lastly, indicators of heart rate variability independently predicted early 
atherosclerosis.  Heart rate variability, a noninvasive indicator of increased CVD risk, is a 
plausible option for widespread clinical application.  These findings emphasize the need to 
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critically evaluate CVD risk on an individual level.  In addition, applying current and new risk 
stratification methods support the important public health objective of reducing the global 
burden of CVD morbidity and mortality through prevention and early detection of CVD.  
 
6.3 FUTURE RESEARCH 
 
Findings from this dissertation offer novel CVD risk factor associations for early 
atherosclerotic changes.  Using these associations to identify people at increased risk is 
only part of the challenge.  Further research is warranted for primary and secondary 
prevention methods targeted at CVD risk.  
 Lipid profile changes during the menopausal transition may lead to increased CVD 
risk due to a shift in HDL particle size.  Conventional behavioral modifications, such as 
smoking cessation, weight reduction, physical activity and moderate alcohol consumption 
have shown to increase HDL-c 101.  However, the HDL particle subfraction that increases 
differs for diet and physical activity 69, 102.  Physical activity is more effective at increasing 
large HDL particles than hypocaloric and low fat diets, which may initially reduce this 
subfraction.  The pharmacologic increases in HDL-c with niacin, fibrates and statins also 
vary by particle size 69.  Niacin has proven to be the most effective agent at increasing HDL-
c, with substantial increases in large HDL particles and minimal changes in small HDL 
particles, whereas fibrates have shown the opposite, an increase in small and decrease in 
large HDL particles.  Research on how women respond to these therapies during the 
menopausal transition is needed.  Tailoring behavioral modification strategies and 
pharmacologic therapy to target an increase in the large HDL particle subfraction may prove 
to slow the burden of CVD among postmenopausal women. 
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The lack of a protective effect from education against early atherosclerotic changes 
among Afro-Caribbean males is a cause for concern.  A community-based approach for 
promoting CVD risk factor reduction involving dietary, physical activity and smoking 
cessation campaigns across community centers, clinics, schools and public places could 
potentially create a network of support.  This network may help improve the likelihood that 
both males and females, across several age ranges, make healthy lifestyle choices.  
Previous community-based prospective studies have shown to be successful at increasing 
fruit and vegetable consumption and regular exercise, while reducing cholesterol, smoking 
and hypertension 103-105.  An ongoing study, involving 15005 individuals in Iran, aims to 
reduce the high burden of hyperlipidemia, hypertension, diabetes and smoking.  The effect 
of primary prevention strategies (public nutrition classes, information pamphlets, religion 
meeting lectures and a school-based lifestyle modification program) and secondary 
prevention strategies (dieticians and smoking clinics) will be monitored over a 20 year 
period 106.  Such community-based strategies are lacking in developing countries of African 
descent; therefore, further research into these methods may be successful at reducing CVD 
burden for Afro-Caribbean males. 
According to recent reports, despite the robustness of CRP as an indicator for CVD 
burden and events, it is not a causal determinate of CVD and including it in risk stratification 
does not improve prediction.  Consequently, therapies targeted at CRP reduction may not 
be beneficial at reducing CVD 96, 107.  The autonomic nervous system modulates 
inflammation via the cholinergic anti-inflammatory pathway.  Therapeutic approaches aimed 
at autonomic activity, including behavioral and pharmacologic methodologies, may be a 
more successful therapeutic strategy than CRP 108.  Omega-3-fatty acid consumption, 
stress reduction through mediation and aerobic conditioning have all shown to increase 
parasympathetic activity and therefore may reduce risk factors and CVD 109-111. 
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In conclusion, future research focusing on primary and secondary prevention 
measures in relation to novel mechanisms for CVD risk may further aid in the reduction of 
the global burden and economic cost of CVD. 
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